USRE31006E
(en)
*
|
1968-09-24 |
1982-08-03 |
Akzona Incorporated |
Process for the demonstration and determination of reaction components having specific binding affinity for each other
|
NL171930C
(en)
*
|
1972-05-11 |
1983-06-01 |
Akzo Nv |
METHOD FOR DETERMINING AND DETERMINING BITES AND TEST PACKAGING.
|
US3790447A
(en)
*
|
1972-07-05 |
1974-02-05 |
Abbott Lab |
Streptococci diagnostic method
|
US4239746A
(en)
*
|
1973-06-30 |
1980-12-16 |
Dezso Istvan Bartos |
Complement fixation test employing reactants in a disposable package
|
DE2333434C3
(en)
*
|
1973-06-30 |
1978-04-06 |
Istvan D. Dr. 5024 Pulheim Bartos |
Process for carrying out serological tests according to the principle of the complement fixation reaction and ready-to-use rapid test pack for this
|
US3935074A
(en)
*
|
1973-12-17 |
1976-01-27 |
Syva Company |
Antibody steric hindrance immunoassay with two antibodies
|
GB1508132A
(en)
*
|
1974-05-20 |
1978-04-19 |
Technicon Instr |
Analysis of biological fluids
|
US4040907A
(en)
*
|
1974-06-20 |
1977-08-09 |
Syva Company |
Iodothyronine enzyme conjugates
|
US4001087A
(en)
*
|
1974-10-10 |
1977-01-04 |
The United States Of America |
Affinity labelling enzymes with esters of aromatic sulfonic acids
|
FR2288312A1
(en)
*
|
1974-10-14 |
1976-05-14 |
Pasteur Institut |
PROGESTERONE IMMUNOENZYMATIC ASSAY PROCESS
|
US4002532A
(en)
*
|
1974-10-21 |
1977-01-11 |
Weltman Joel K |
Enzyme conjugates
|
SE388694B
(en)
*
|
1975-01-27 |
1976-10-11 |
Kabi Ab |
WAY TO PROVIDE AN ANTIGEN EXV IN SAMPLES OF BODY WHEATS, USING POROST BERAR MATERIAL BONDED OR ADSORBING ANTIBODIES
|
NL7501215A
(en)
*
|
1975-02-01 |
1976-08-03 |
Akzo Nv |
METHOD FOR DETERMINING AND DETERMINING AN ANTIGEN OR ANTIBODY.
|
US4629688A
(en)
*
|
1975-04-28 |
1986-12-16 |
Miles Laboratories, Inc. |
Homogeneous specific binding assay method
|
US4230797A
(en)
*
|
1975-04-28 |
1980-10-28 |
Miles Laboratories, Inc. |
Heterogenous specific binding assay employing a coenzyme as label
|
USRE32696E
(en)
*
|
1975-09-04 |
1988-06-14 |
Akzona Incorporated |
Enzymatic immunological method for determination of antigens and antibodies
|
US4642285A
(en)
*
|
1975-09-29 |
1987-02-10 |
Diamedix Corporation |
Sandwich EIA for antigen
|
SE7610683L
(en)
*
|
1975-09-29 |
1977-06-10 |
Cordis Corp |
METHOD OF DETERMINING THE NERVARON OF AN ANTIGEN ASSOCIATE WITH HEPATITIS
|
US4474878A
(en)
*
|
1975-09-29 |
1984-10-02 |
Cordis Laboratories, Inc. |
Sandwich EIA for antigen associated with hepatitis
|
JPS5272284A
(en)
*
|
1975-12-12 |
1977-06-16 |
Dainippon Pharmaceutical Co |
Enzymeeimmunoassay reagent
|
US4045384A
(en)
*
|
1976-07-23 |
1977-08-30 |
The Dow Chemical Company |
Method for forming an amide bond between a latex and protein
|
GB1549069A
(en)
*
|
1976-12-10 |
1979-08-01 |
Erba Farmitalia |
Enzyme linked immunoassay
|
US4407943A
(en)
*
|
1976-12-16 |
1983-10-04 |
Millipore Corporation |
Immobilized antibody or antigen for immunoassay
|
US4200690A
(en)
*
|
1976-12-16 |
1980-04-29 |
Millipore Corporation |
Immunoassay with membrane immobilized antibody
|
JPS5399319A
(en)
*
|
1977-02-09 |
1978-08-30 |
Hidematsu Hirai |
Novel qualitative and quantitative detecting method and detecting body for antgenic substance
|
IT1114861B
(en)
*
|
1977-05-12 |
1986-01-27 |
Sclavo Inst Sieroterapeut |
METHOD FOR DETERMINING THE CONTENT OF CONSTITUENTS OF BIOLOGICAL FLUIDS AND MEANS SUITABLE FOR THE PURPOSE
|
AU531777B2
(en)
*
|
1978-04-05 |
1983-09-08 |
Syva Co. |
Label/solid conjugate immunoassay system
|
US4233402A
(en)
*
|
1978-04-05 |
1980-11-11 |
Syva Company |
Reagents and method employing channeling
|
US4318980A
(en)
*
|
1978-04-10 |
1982-03-09 |
Miles Laboratories, Inc. |
Heterogenous specific binding assay employing a cycling reactant as label
|
US4492751A
(en)
*
|
1978-04-10 |
1985-01-08 |
Miles Laboratories, Inc. |
Heterogenous specific binding assay employing an enzyme substrate as label
|
US5605800A
(en)
*
|
1978-04-13 |
1997-02-25 |
Institut Pasteur |
Method of detecting and characterizing a nucleic acid or a sequence of the latter, and enzymatic reactant for the application of this method
|
FR2422956A1
(en)
*
|
1978-04-13 |
1979-11-09 |
Pasteur Institut |
METHOD OF DETECTION AND CHARACTERIZATION OF A NUCLEIC ACID OR OF A SEQUENCE OF THE SAME, AND ENZYMATIC REAGENT FOR THE IMPLEMENTATION OF THIS PROCESS
|
JPS5510590A
(en)
*
|
1978-05-04 |
1980-01-25 |
Wellcome Found |
Enzyme immunity quantity analysis
|
JPS5539702A
(en)
*
|
1978-08-30 |
1980-03-19 |
Takeda Chem Ind Ltd |
Method of measuring enzyme immunity of pancreas glucagon
|
FR2440555A1
(en)
*
|
1978-10-31 |
1980-05-30 |
Maes Roland |
IMPROVEMENTS IN METHODS OF DETERMINING SUBSTANCES SHOWING SPECIFIC BINDING AFFINITIES BETWEEN THEM, BY TESTS INVOLVING A SOLID PHASE
|
US4260678A
(en)
*
|
1979-02-23 |
1981-04-07 |
Corning Glass Works |
Determining creatine kinase isoenzmes via immobilized antibody-isoenzyme complexes
|
JPS55152459A
(en)
*
|
1979-05-18 |
1980-11-27 |
Yamasa Shoyu Co Ltd |
Method and reagent for measuring quantity of cyclic nucleotide
|
US4289748A
(en)
*
|
1979-05-31 |
1981-09-15 |
United States Of America |
Ultrasensitive enzymatic radioimmunoassay method
|
DE2930706A1
(en)
*
|
1979-07-28 |
1981-02-05 |
Medac Klinische Spezialpraep |
METHOD FOR DETECTING POTENTIAL-SPECIFIC ANTIBODY
|
US4299916A
(en)
*
|
1979-12-26 |
1981-11-10 |
Syva Company |
Preferential signal production on a surface in immunoassays
|
US4394391A
(en)
*
|
1980-02-19 |
1983-07-19 |
Thorell Jan Ivan |
Radioimmunoassay reagents
|
US4322495A
(en)
*
|
1980-03-11 |
1982-03-30 |
Minnesota Mining And Manufacturing Co. |
Immunoassay
|
SE8003732L
(en)
*
|
1980-05-19 |
1981-11-20 |
Pharmacia Diagnostics Ab |
SET FOR DETERMINATION METHODS INVOLVING BIOSPECIFIC AFFINITY REACTIONS
|
EP0040728A1
(en)
*
|
1980-05-19 |
1981-12-02 |
Pharmacia Diagnostics Ab |
An improvement in and relating to assaying methods involving biospecific affinity reactions
|
JPS5714748A
(en)
*
|
1980-07-01 |
1982-01-26 |
Dainippon Pharmaceut Co Ltd |
Kit for quantitative determination of valproic acid and its method for quantitative determination
|
US4323647A
(en)
*
|
1980-10-15 |
1982-04-06 |
University Of Miami |
Steric hindrance enzyme immunoassay
|
DE3048884A1
(en)
*
|
1980-12-23 |
1982-07-15 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
METHOD FOR ENZYME IMMUNE DETERMINATION IN HETEROGENEOUS PHASE
|
ES511156A0
(en)
*
|
1981-04-13 |
1983-08-01 |
Hoechst Co American |
A METHOD OF DETERMINING THE PRESENCE OF AN ANTIGEN IN A LIQUID MEDIUM SUSPECTED TO CONTAIN IT.
|
US4604365A
(en)
*
|
1981-06-02 |
1986-08-05 |
Electro-Nucleonics, Inc. |
Immunoprecipitation assay
|
WO1982004323A1
(en)
*
|
1981-06-02 |
1982-12-09 |
O Neill Sean |
Immunoprecipitation assay
|
US4506009A
(en)
*
|
1982-03-30 |
1985-03-19 |
University Of California |
Heterogeneous immunoassay method
|
US4535057A
(en)
*
|
1982-07-26 |
1985-08-13 |
Amf Incorporated |
Immunoassay employing monoclonal herpes simplex antibody and biotin-avidin detection system
|
US4515890A
(en)
*
|
1982-11-08 |
1985-05-07 |
Abbott Laboratories |
Immunoassay of terminal deoxynucleotidyl transferase
|
US4650751A
(en)
*
|
1983-04-29 |
1987-03-17 |
Technicon Instruments Corporation |
Protected binding assay avoiding non-specific protein interference
|
US4778752A
(en)
*
|
1983-10-11 |
1988-10-18 |
Scripps Clinic And Research Foundation |
Receptors specific for hapten-modified self proteins
|
AU593795B2
(en)
*
|
1985-03-18 |
1990-02-22 |
Royal Free Hospital School Of Medicine |
Improvements relating to the detection of cytomegalovirus and antibodies
|
JPS62148857A
(en)
*
|
1985-12-24 |
1987-07-02 |
Toyo Soda Mfg Co Ltd |
Production of material for immunological measurement
|
EP0247730A3
(en)
*
|
1986-04-28 |
1989-04-12 |
Antibody Technology Limited |
Antibodies, their preparation and use and products containing them
|
DE3636724A1
(en)
*
|
1986-10-29 |
1988-06-23 |
Joern Dr Med Kekow |
Enzyme immunoassay (ELISA) for determining insulin in an microtitre plate system
|
US6528292B1
(en)
*
|
1987-05-29 |
2003-03-04 |
Aventis Pharmaceuticals Holdings Inc. |
Derivatized polystyrene and other polymer supports for spectroscopic studies
|
US5256372A
(en)
*
|
1987-11-06 |
1993-10-26 |
Idexx Corporation |
Dipstick test device including a removable filter assembly
|
US5137804A
(en)
*
|
1988-05-10 |
1992-08-11 |
E. I. Du Pont De Nemours And Company |
Assay device and immunoassay
|
US5374524A
(en)
*
|
1988-05-10 |
1994-12-20 |
E. I. Du Pont De Nemours And Company |
Solution sandwich hybridization, capture and detection of amplified nucleic acids
|
US5614504A
(en)
*
|
1990-08-01 |
1997-03-25 |
The University Of South Florida |
Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
|
US5965379A
(en)
*
|
1991-07-19 |
1999-10-12 |
Cytimmune Sciences Inc. |
Method for measuring endogenous cytokines
|
WO1993002359A1
(en)
*
|
1991-07-19 |
1993-02-04 |
Assay Research, Inc. |
Method and kit for measuring endogenous cytokines
|
US5464749A
(en)
|
1991-07-22 |
1995-11-07 |
Bayer Corporation |
Immunoassay of free substances in biological fluids
|
US5874423A
(en)
*
|
1992-09-10 |
1999-02-23 |
Yissum Research Development Co. Of The Hebrew University Of Jerusalem |
Digitalis-like compounds
|
US5637467A
(en)
*
|
1992-10-13 |
1997-06-10 |
Behringwerke Ag |
Heterogeneous assay using a pendulous drop
|
WO1995034640A1
(en)
*
|
1994-06-13 |
1995-12-21 |
Henry Ford Health System |
A novel neuronal-neonatal gene: neuronatin
|
US5843673A
(en)
*
|
1994-10-25 |
1998-12-01 |
Curators Of The University Of Missouri |
Method of screening for endometriosis
|
US6531277B2
(en)
|
1994-10-25 |
2003-03-11 |
The Curators Of The University Of Missouri |
Endometriosis-specific secretory protein
|
US20030152909A1
(en)
*
|
1994-11-16 |
2003-08-14 |
Mitrani Eduardo N. |
In vitro micro-organs, and uses related thereto
|
US5607565A
(en)
*
|
1995-03-27 |
1997-03-04 |
Coulter Corporation |
Apparatus for measuring analytes in a fluid sample
|
US5858661A
(en)
*
|
1995-05-16 |
1999-01-12 |
Ramot-University Authority For Applied Research And Industrial Development |
Ataxia-telangiectasia gene and its genomic organization
|
US5777093A
(en)
*
|
1995-05-16 |
1998-07-07 |
Ramot-University Authority For Applied Research & Industrial Development Ltd. |
cDNAs associated with ataxia-telangiectasia
|
US5728807A
(en)
*
|
1995-05-16 |
1998-03-17 |
Ramot-University Authority For Applied Research And Industrial Development, Ltd. |
Mutated proteins associated with ataxia-telangiectasia
|
US6096508A
(en)
*
|
1995-08-16 |
2000-08-01 |
Kirkegaard & Perry Laboratoies, Inc. |
Method of reducing background in biotin-based assays
|
US5840322A
(en)
*
|
1996-12-19 |
1998-11-24 |
Ramot-University Authority For Applied Research & Industrial Devel. Ltd. |
Anti-oral-microbial adhesion fraction derived from vaccinium
|
US7973156B2
(en)
|
1997-08-21 |
2011-07-05 |
Quark Pharmaceuticals Inc. |
Hypoxia-regulated genes
|
EP1009753B1
(en)
*
|
1997-08-21 |
2005-04-20 |
Quark Biotech, Inc. |
Hypoxia-regulated genes
|
US6284496B1
(en)
|
1997-10-03 |
2001-09-04 |
University Of South Florida |
DNA vector for determining the presence of out-of-reading-frame mutations
|
CA2307345A1
(en)
|
1997-10-17 |
1999-04-29 |
University Of South Florida |
Method to diagnose and monitor cellular immune deficiencies
|
US7687057B2
(en)
|
1998-01-09 |
2010-03-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
In vitro micro-organs, and uses related thereto
|
WO2000018885A1
(en)
|
1998-09-29 |
2000-04-06 |
Gamida Cell Ltd. |
Methods of controlling proliferation and differentiation of stem and progenitor cells
|
US20080206206A1
(en)
|
1998-05-07 |
2008-08-28 |
University Of South Florida |
Bone marrow-derived neuronal cells
|
US6344443B1
(en)
|
1998-07-08 |
2002-02-05 |
University Of South Florida |
Peptide antagonists of tumor necrosis factor alpha
|
WO2000002561A1
(en)
|
1998-07-13 |
2000-01-20 |
University Of South Florida |
Modulation of the phospholipase a2 pathway as a therapeutic
|
US6187563B1
(en)
|
1998-08-07 |
2001-02-13 |
Yale University |
βIV-spectrin-polypeptides and nucleic acids encoding same
|
NZ513303A
(en)
|
1999-02-04 |
2003-03-28 |
Technion Res & Dev Foundation |
Three dimensional plug flow bioreactor, and its use for the maintenance and expansion of hemopoietic stem cells and/or progenitor cells
|
US6440682B1
(en)
*
|
1999-05-28 |
2002-08-27 |
Detroit R&D Inc. |
Detection of hypertension using immunoreactive metabolic products
|
US6787318B1
(en)
*
|
1999-06-01 |
2004-09-07 |
Roskamp Research Institute, Llc |
Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
|
US7534605B2
(en)
|
1999-06-08 |
2009-05-19 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
|
WO2001000859A1
(en)
*
|
1999-06-25 |
2001-01-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Method of inducing angiogenesis by micro-organs
|
US6875582B1
(en)
|
1999-08-19 |
2005-04-05 |
Omniscience Pharmaceuticals, Inc. |
Methods and targets of antibiotic resistance
|
US7101839B1
(en)
|
1999-08-30 |
2006-09-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
US7811981B2
(en)
*
|
1999-08-30 |
2010-10-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
US6998232B1
(en)
|
1999-09-27 |
2006-02-14 |
Quark Biotech, Inc. |
Methods of diagnosing bladder cancer
|
WO2001036586A2
(en)
*
|
1999-11-19 |
2001-05-25 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Aspegillus niger beta-glucosidase gene, protein and uses thereof
|
US6544506B2
(en)
|
2000-01-05 |
2003-04-08 |
Yeda Research & Development Co. Ltd. |
Veto cells effective in preventing graft rejection and devoid of graft versus host potential
|
US7385106B2
(en)
*
|
2000-01-24 |
2008-06-10 |
Ramot At Tel Aviv University Ltd. |
Plants tolerant of environmental stress conditions, methods of generating same and novel polynucleotide sequence utilized thereby
|
EP1294748B1
(en)
|
2000-03-27 |
2010-06-30 |
Technion Research and Development of Foundation, Ltd. |
Single chain class i major histo-compatibility complexes, constructs encoding same and methods of generating same
|
US20040191260A1
(en)
*
|
2003-03-26 |
2004-09-30 |
Technion Research & Development Foundation Ltd. |
Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
|
IL135884A
(en)
*
|
2000-04-30 |
2005-08-31 |
Yissum Res Dev Co |
Method for measuring non-transferrin bound iron
|
HUP0300810A2
(en)
|
2000-07-20 |
2003-08-28 |
M.G.V.S. Ltd. |
Artifical vascular grafts, and methods of producing and using same
|
US20040037828A1
(en)
|
2002-07-09 |
2004-02-26 |
Bar-Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
US20030114410A1
(en)
|
2000-08-08 |
2003-06-19 |
Technion Research And Development Foundation Ltd. |
Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
|
DE60143754D1
(en)
|
2000-08-08 |
2011-02-10 |
Technion Res And Dev Of Foundation Ltd |
PHARMACEUTICAL COMPOSITIONS AND METHODS USEFUL FOR THE TREATMENT OF CANCER OR LIVER FIBROSIS
|
EP1683874A3
(en)
|
2000-08-29 |
2006-10-11 |
YEDA RESEARCH AND DEVELOPMENT Co. LTD. |
Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents
|
AU2001295850A1
(en)
*
|
2000-09-28 |
2002-04-08 |
Nanocyte Inc. |
Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
|
US7632522B2
(en)
|
2000-09-28 |
2009-12-15 |
Nanocyte Inc. |
Use of stinging cells/capsules for the delivery of active agents to keratinous substances
|
US20070281037A9
(en)
*
|
2000-09-28 |
2007-12-06 |
Nanocyte Inc. |
Sterile preparations and compositions including stinging capsules and methods of producing and using same
|
US8071740B2
(en)
|
2000-11-17 |
2011-12-06 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
|
CA2429342C
(en)
|
2000-11-17 |
2013-03-19 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same
|
EP1341543A4
(en)
|
2000-11-24 |
2009-09-02 |
Vascular Biogenics Ltd |
Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
|
WO2002043651A2
(en)
*
|
2000-11-30 |
2002-06-06 |
Yeda Research And Development Co. Ltd. |
Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease
|
US20040106120A1
(en)
|
2000-11-30 |
2004-06-03 |
Rachid Tazi-Ahnini |
Diagnosis and treatment of disease
|
AU2002236608A1
(en)
*
|
2000-12-14 |
2002-06-24 |
Nyxis Neurotherapies, Inc. |
High throughput assay to detect inhibitors of the map kinase pathway
|
US7087395B1
(en)
|
2001-01-16 |
2006-08-08 |
Quest Diagnostics Investments Incorporated |
Vitamin D assay
|
KR20040101889A
(en)
*
|
2001-01-17 |
2004-12-03 |
라모트 앳 텔-아비브 유니버시티 리미티드 |
Chitinases, derived from carnivorous plants polynucleotide sequences encoding thereof, and methods of isolating and using same
|
US20050202098A1
(en)
*
|
2001-01-31 |
2005-09-15 |
Tolaren |
Disease therapy using dying or dead cells
|
US20050031618A1
(en)
*
|
2001-01-31 |
2005-02-10 |
Dror Mevorach |
Induction of tolerance by apoptotic and/or necrotic cells
|
US20030003454A1
(en)
|
2001-03-23 |
2003-01-02 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a DNA repair enzyme and a cancer
|
US6770622B2
(en)
|
2001-06-08 |
2004-08-03 |
Gary A. Jarvis |
N-terminally truncated galectin-3 for use in treating cancer
|
MXPA04000397A
(en)
*
|
2001-07-19 |
2004-03-18 |
Yissum Res Dev Co |
Polypeptides having carotenoids isomerase catalytic activity, nucleic acids encoding same and uses thereof.
|
US7442781B2
(en)
|
2001-08-16 |
2008-10-28 |
Urifer Ltd. |
Diagnosis, prevention and treatment of cancer
|
US20040136972A1
(en)
|
2001-09-07 |
2004-07-15 |
Yeda Research And Development Co. Ltd. |
Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
|
US7138144B2
(en)
*
|
2001-09-07 |
2006-11-21 |
Nadir Askenasy |
Method of inducing immune tolerance via blood/lymph flow-restricted bone marrow transplantation
|
EP2223932A1
(en)
|
2001-10-19 |
2010-09-01 |
Vascular Biogenics Ltd. |
Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
|
AUPR842501A0
(en)
*
|
2001-10-23 |
2001-11-15 |
Epipop Pty Ltd |
A method for identification and development of therapeutic agents
|
AU2002358947A1
(en)
*
|
2001-12-05 |
2003-06-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nanoparticles containing polymeric nucleic acid homologs, pharmaceutical compositions and articles of manufacture containing same and methods of use thereof
|
US20050085432A1
(en)
*
|
2001-12-26 |
2005-04-21 |
Aviva Lapidot |
Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
|
IL152904A0
(en)
|
2002-01-24 |
2003-06-24 |
Gamida Cell Ltd |
Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
|
EP1465982A4
(en)
|
2002-01-25 |
2006-06-07 |
Gamida Cell Ltd |
Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby
|
US20040052928A1
(en)
*
|
2002-09-06 |
2004-03-18 |
Ehud Gazit |
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
|
US7781396B2
(en)
*
|
2002-01-31 |
2010-08-24 |
Tel Aviv University Future Technology Development L.P. |
Peptides directed for diagnosis and treatment of amyloid-associated disease
|
US6992176B2
(en)
|
2002-02-13 |
2006-01-31 |
Technion Research & Development Foundation Ltd. |
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
|
AU2003216341A1
(en)
*
|
2002-02-20 |
2003-09-09 |
Dyax Corporation |
Mhc-peptide complex binding ligands
|
US20050220774A1
(en)
*
|
2002-03-18 |
2005-10-06 |
Tony Peled |
Methods of inducing differentiation in ex vivo expanded stem cells
|
ATE394125T1
(en)
*
|
2002-03-26 |
2008-05-15 |
Nanocyte Inc |
NETTLE CELLS EXPRESSING AN EXOGENEOUS POLYNUCLEOTIDE ENCODING A THERAPEUTIC, DIAGNOSTIC OR COSMETIC AGENT AND METHODS, COMPOSITIONS AND DEVICES USING SUCH NETTLE CELLS OR CAPSULES DERIVED THEREOF TO DELIVER THE THERAPEUTIC, DIAGNOSTIC OR COSMETIC AGENT INTO A TISSUE BE
|
US20040121442A1
(en)
*
|
2002-05-05 |
2004-06-24 |
Ilan Chet |
Fungal chitinase, polynucleotide sequences encoding same, promoters of same, and uses thereof
|
JP2005533102A
(en)
*
|
2002-07-12 |
2005-11-04 |
イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム |
Method and apparatus for inducing biological processes by micro-organs
|
EP2561889A3
(en)
|
2002-08-01 |
2013-04-03 |
Yeda Research and Development Co. Ltd. |
Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
|
US7267981B2
(en)
|
2002-10-07 |
2007-09-11 |
Technion Research & Development Foundation Ltd. |
Human foreskin fibroblasts for culturing ES cells
|
AU2003284968A1
(en)
*
|
2002-10-25 |
2004-05-13 |
University Of South Florida |
Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease
|
WO2004040252A2
(en)
|
2002-10-30 |
2004-05-13 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Molecules and methods using same for measuring non-transferrin bound iron
|
US20050054097A1
(en)
*
|
2002-11-17 |
2005-03-10 |
Tony Peled |
EX-VIVO expansion of hematopoietic system cell populations in mononuclear cell cultures
|
US7947499B2
(en)
*
|
2002-11-29 |
2011-05-24 |
Technion Research & Development Foundation Ltd. |
Method of dynamically culturing embryonic stem cells
|
US7491699B2
(en)
*
|
2002-12-09 |
2009-02-17 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures and methods of generating and using the same
|
US7422734B2
(en)
|
2002-12-12 |
2008-09-09 |
R.B.T. (Rakuto Bio Technologies) Ltd. |
Methods of producing lignin peroxidase and its use in skin and hair lightening
|
DK1572984T3
(en)
|
2002-12-16 |
2016-06-13 |
Technion Res & Dev Foundation |
FEEDER CELL-FREE, XENOPHRIC CULTIVATION SYSTEM FOR HUMAN EMBRYONAL STEM CELLS
|
ATE546548T1
(en)
|
2003-01-02 |
2012-03-15 |
Rappaport Family Inst For Res |
METHOD FOR PREDICTING THE BENEFIT OF ANTI-OXIDATION THERAPY FOR PREVENTING CARDIOVASCULAR DISEASE IN HYPERGLYCEMIC PATIENTS
|
EP1583713B1
(en)
*
|
2003-01-07 |
2009-03-25 |
Ramot at Tel Aviv University Ltd. |
Peptide nanostructures encapsulating a foreign material and method of manufacturing same
|
US7786071B2
(en)
|
2003-03-04 |
2010-08-31 |
Yeda Research And Development Co. Ltd. |
Pon polypeptides polynucleotides encoding same and compositions and methods utilizing same
|
AU2004217699B2
(en)
*
|
2003-03-07 |
2008-07-03 |
Gamida-Cell Ltd. |
Expansion of renewable stem cell populations using modulators of PI 3-kinase
|
US8017113B2
(en)
|
2003-03-12 |
2011-09-13 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions and methods for diagnosing and treating an inflammation
|
US7294701B2
(en)
*
|
2003-04-02 |
2007-11-13 |
Technion Research & Development Foundation Ltd. |
Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
|
DK2330132T3
(en)
|
2003-04-04 |
2013-11-04 |
Yeda Res & Dev |
Antibodies to MMP2 or MMP9 and pharmaceutical compositions thereof to inhibit their metalloprotein activity
|
JP4865540B2
(en)
|
2003-04-08 |
2012-02-01 |
イエダ リサーチ アンド ディベロップメント カンパニー リミテッド |
Stem cells with increased sensitivity to chemoattractants and methods of producing and using the same
|
FR2853551B1
(en)
|
2003-04-09 |
2006-08-04 |
Lab Francais Du Fractionnement |
STABILIZING FORMULATION FOR IMMUNOGLOBULIN G COMPOSITIONS IN LIQUID FORM AND LYOPHILIZED FORM
|
US7321065B2
(en)
*
|
2003-04-18 |
2008-01-22 |
The Regents Of The University Of California |
Thyronamine derivatives and analogs and methods of use thereof
|
US7554007B2
(en)
*
|
2003-05-22 |
2009-06-30 |
Evogene Ltd. |
Methods of increasing abiotic stress tolerance and/or biomass in plants
|
EP2365087A3
(en)
|
2003-05-22 |
2011-11-30 |
Evogene Ltd. |
Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby
|
AU2005234725B2
(en)
|
2003-05-22 |
2012-02-23 |
Evogene Ltd. |
Methods of Increasing Abiotic Stress Tolerance and/or Biomass in Plants and Plants Generated Thereby
|
US20050020499A1
(en)
*
|
2003-05-27 |
2005-01-27 |
Bar Ilan University |
Methods of attenuating cocaine seeking behavior employing glial cell-derived neurotrophic factor (GDNF) and pharmaceutical compositions and articles of manufacture suited for use in practice of the method
|
US8129514B2
(en)
*
|
2003-06-19 |
2012-03-06 |
Evogene Ltd. |
Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
|
EP1636333A4
(en)
*
|
2003-06-19 |
2007-10-24 |
Evogene Ltd |
Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
|
JP5137400B2
(en)
|
2003-06-30 |
2013-02-06 |
テル アヴィヴ ユニヴァーシティ フューチャー テクノロジー ディヴェロップメント エル.ピー. |
Peptides for diagnosing and treating amyloid-related diseases, antibodies thereto, and methods of use thereof
|
MXPA06001722A
(en)
*
|
2003-08-14 |
2006-05-19 |
Bio Balance Corp |
Bacterial strains, compositions including same and probiotic use thereof.
|
WO2005031362A2
(en)
|
2003-10-02 |
2005-04-07 |
Ramot At Tel Aviv University Ltd. |
Novel antibacterial agents and methods of identifying and utilizing same
|
IL158287A0
(en)
|
2003-10-07 |
2004-05-12 |
Yeda Res & Dev |
Antibodies to nik, their preparation and use
|
ATE509034T1
(en)
|
2003-10-07 |
2011-05-15 |
Yeda Res & Dev |
ANTIBODIES TO NIK, THEIR PRODUCTION AND USE
|
JP2007508837A
(en)
*
|
2003-10-23 |
2007-04-12 |
ファイザー・プロダクツ・インク |
Vaccine for periodontal disease
|
AU2004292872B2
(en)
|
2003-11-30 |
2012-04-19 |
Yeda Research And Development Co. Ltd |
Methods and agents for immune modulation and methods for identifying immune modulators
|
WO2005059100A2
(en)
*
|
2003-12-12 |
2005-06-30 |
New York University |
Methods and compositions relating to cystatin c
|
US20100221233A1
(en)
*
|
2003-12-15 |
2010-09-02 |
University Of South Florida |
Compositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers
|
DK1722834T3
(en)
|
2003-12-22 |
2012-10-22 |
Regentis Biomaterials Ltd |
Matrix, which includes naturally occurring cross-linked protein skeleton
|
US8007847B2
(en)
|
2004-01-13 |
2011-08-30 |
Eytan Biderman |
Feeding formula appliance
|
US7423139B2
(en)
*
|
2004-01-20 |
2008-09-09 |
Insight Biopharmaceuticals Ltd. |
High level expression of recombinant human erythropoietin having a modified 5′-UTR
|
WO2005071058A2
(en)
*
|
2004-01-27 |
2005-08-04 |
Compugen Ltd. |
Methods and systems for annotating biomolecular sequences
|
WO2005084699A1
(en)
|
2004-03-02 |
2005-09-15 |
Acceleron Pharma Inc. |
Alk7 and myostatin inhibitors and uses thereof
|
US8352031B2
(en)
|
2004-03-10 |
2013-01-08 |
Impulse Dynamics Nv |
Protein activity modification
|
AU2005252469B2
(en)
*
|
2004-06-14 |
2011-07-21 |
Evogene Ltd. |
Polynucleotides and polypeptides involved in plant fiber development and methods of using same
|
US8680062B2
(en)
*
|
2004-07-06 |
2014-03-25 |
Deliversir Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
US20090156471A1
(en)
*
|
2004-07-15 |
2009-06-18 |
Ramot At Tel Aviv University Ltd. |
Use of anti-amyloid agents for treating and typing pathogen infections
|
WO2006030442A2
(en)
|
2004-09-16 |
2006-03-23 |
Gamida-Cell Ltd. |
Methods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells
|
US20060095241A1
(en)
*
|
2004-10-29 |
2006-05-04 |
Microsoft Corporation |
Systems and methods that utilize machine learning algorithms to facilitate assembly of aids vaccine cocktails
|
US8000900B2
(en)
|
2004-09-21 |
2011-08-16 |
Microsoft Corporation |
Association-based predictions of pathogen characteristics
|
EP1809751B1
(en)
|
2004-09-29 |
2010-09-01 |
CollPlant Ltd. |
Collagen producing plants and methods of generating and using same
|
EP1805319B1
(en)
*
|
2004-09-29 |
2014-09-03 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Recombinant human t2 rnase and uses thereof
|
US7781402B2
(en)
*
|
2004-10-12 |
2010-08-24 |
Closed Loop Therapies Ltd. |
Methods and implantable devices for treating supraventricular arrhythmias
|
US8478535B2
(en)
|
2004-10-29 |
2013-07-02 |
Microsoft Corporation |
Systems and methods that utilize machine learning algorithms to facilitate assembly of aids vaccine cocktails
|
US20060134680A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Alexander Kotlyar |
Homogeneous populations of nucleic acids, methods of synthesyzing same and uses thereof
|
JP2008527563A
(en)
|
2005-01-16 |
2008-07-24 |
ズランゴー リミテッド |
Iconic communication
|
US20080082678A1
(en)
*
|
2005-01-16 |
2008-04-03 |
Zlango Ltd. |
Communications Network System and Methods for Using Same
|
US8019818B2
(en)
*
|
2005-01-18 |
2011-09-13 |
Zlango Ltd. |
Communications network system and methods for using same
|
EP3028765B1
(en)
|
2005-01-31 |
2020-01-08 |
Realbio Technologies Ltd. |
Method of sequentially transferring liquids through a lateral flow capillary device
|
EP2316441A1
(en)
|
2005-02-17 |
2011-05-04 |
Hadasit Medical Research Services And Development |
Bisphosphonates for treating endometriosis
|
JP5432455B2
(en)
|
2005-02-25 |
2014-03-05 |
ザ ステート オブ イスラエル、ミニストリー オブ アグリカルチャー アンド ルーラル ディベロップメント、アグリカルチュラル リサーチ オーガナイゼイション、(エー.アール.オー.)、ボルカニ センター |
Fruit cell culture extract for inflammation treatment
|
US7695927B2
(en)
*
|
2005-03-18 |
2010-04-13 |
Detroit R & D |
Detection of hypertension using glucuronidated metabolic products
|
US20090068207A1
(en)
*
|
2005-04-15 |
2009-03-12 |
Vascular Biogenics Ltd. |
Compositions Containing Beta 2-Glycoprotein I-Derived Peptides for the Prevention and/or Treatment of Vascular Disease
|
US8834862B2
(en)
*
|
2005-04-19 |
2014-09-16 |
Nanocyte Inc. |
Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
|
CA2606018A1
(en)
*
|
2005-04-28 |
2006-11-02 |
Ventana Medical Systems, Inc. |
Nanoparticle conjugates
|
ES2609919T3
(en)
|
2005-04-28 |
2017-04-25 |
Ventana Medical Systems, Inc. |
Enzymes conjugated to antibodies using a heterobifunctional PEG linker
|
US9943481B2
(en)
|
2005-05-26 |
2018-04-17 |
Biorest Ltd. |
Compositions and methods using same for delivering agents into a target organ protected by a blood barrier
|
WO2006134602A2
(en)
|
2005-06-16 |
2006-12-21 |
Ramot At Tel Aviv University Ltd. |
Isolated cells and populations comprising same for the treatment of cns diseases
|
US20070225242A1
(en)
*
|
2005-06-21 |
2007-09-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method and composition for treating and preventing tumor metastasis in vivo
|
JP5086254B2
(en)
|
2005-07-07 |
2012-11-28 |
フルクルム エスピー リミテッド |
SP1 polypeptides, modified SP1 polypeptides and uses thereof
|
AU2006267841B2
(en)
|
2005-07-07 |
2011-12-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nucleic acid agents for downregulating H19, and methods of using same
|
US20110070201A1
(en)
|
2005-07-18 |
2011-03-24 |
Protalix Ltd. |
Mucosal or enteral administration of biologically active macromolecules
|
US7993657B2
(en)
|
2005-07-26 |
2011-08-09 |
University Of Medicine And Dentistry Of New Jersey |
Antibody profiles characteristic of tuberculosis state
|
WO2007019541A2
(en)
*
|
2005-08-08 |
2007-02-15 |
Onconon, Llc. |
Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
|
EP1928479B1
(en)
|
2005-08-24 |
2016-06-08 |
Yeda Research And Development Co., Ltd. |
Universal donor-derived tolerogenic cells for inducing non-syngeneic transplantation tolerance
|
SG177946A1
(en)
|
2005-08-29 |
2012-02-28 |
Technion Res & Dev Foundation |
Media for culturing stem cells
|
US8034914B2
(en)
*
|
2005-09-22 |
2011-10-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nucleic acid constructs, pharmaceutical compositions and methods of using same for treating cancer
|
US20070087437A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Jifan Hu |
Methods for rejuvenating cells in vitro and in vivo
|
RU2425151C2
(en)
|
2005-10-24 |
2011-07-27 |
Эвоген Лтд. |
Isolated polypeptides, coding polynucleotides, expressing transgenic plants and methods of their usage
|
WO2007057967A1
(en)
*
|
2005-11-18 |
2007-05-24 |
Mitsubishi Denki Kabushiki Kaisha |
Device for lighting elevator car
|
ES2804129T3
(en)
*
|
2005-11-23 |
2021-02-03 |
Ventana Med Syst Inc |
Antibody-enzyme conjugate
|
BRPI0620523A2
(en)
|
2005-11-29 |
2011-11-16 |
Gamida Cell Ltd |
method of increasing implant potential and cell attraction, method of preparing cells for transplantation in a subject, cell population and pharmaceutical composition
|
US8846393B2
(en)
|
2005-11-29 |
2014-09-30 |
Gamida-Cell Ltd. |
Methods of improving stem cell homing and engraftment
|
EP2032984A1
(en)
|
2005-12-12 |
2009-03-11 |
Gyros Patent Ab |
Microfluidic assays and microfluidic devices
|
US20070134739A1
(en)
*
|
2005-12-12 |
2007-06-14 |
Gyros Patent Ab |
Microfluidic assays and microfluidic devices
|
US8775526B2
(en)
|
2006-01-16 |
2014-07-08 |
Zlango Ltd. |
Iconic communication
|
US8048848B2
(en)
|
2006-02-03 |
2011-11-01 |
Prolor Biotech Ltd. |
Long-acting interferons and derivatives thereof and methods thereof
|
US9458444B2
(en)
|
2006-02-03 |
2016-10-04 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US20140113860A1
(en)
|
2006-02-03 |
2014-04-24 |
Prolor Biotech Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US10351615B2
(en)
|
2006-02-03 |
2019-07-16 |
Opko Biologics Ltd. |
Methods of treatment with long-acting growth hormone
|
US20150038413A1
(en)
|
2006-02-03 |
2015-02-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US7553940B2
(en)
|
2006-02-03 |
2009-06-30 |
Modigene Inc |
Long-acting EPO polypeptides and derivatives thereof and methods thereof
|
US9249407B2
(en)
|
2006-02-03 |
2016-02-02 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US8450269B2
(en)
|
2006-02-03 |
2013-05-28 |
Prolor Biotech Ltd. |
Long-acting growth hormone and methods of producing same
|
US8946155B2
(en)
|
2006-02-03 |
2015-02-03 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US10221228B2
(en)
|
2006-02-03 |
2019-03-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8048849B2
(en)
|
2006-02-03 |
2011-11-01 |
Modigene, Inc. |
Long-acting polypeptides and methods of producing same
|
US8759292B2
(en)
|
2006-02-03 |
2014-06-24 |
Prolor Biotech, Llc |
Long-acting coagulation factors and methods of producing same
|
US8476234B2
(en)
|
2006-02-03 |
2013-07-02 |
Prolor Biotech Inc. |
Long-acting coagulation factors and methods of producing same
|
CA2641079A1
(en)
|
2006-02-06 |
2007-08-16 |
Rappaport Family Institute For Research In The Medical Sciences |
Methods and kit for diagnosing t1dm
|
EP1991852B1
(en)
|
2006-03-06 |
2015-07-01 |
Zetiq Technologies Ltd. |
Methods for identifying a cell phenotype
|
DK2626417T3
(en)
|
2006-03-23 |
2015-11-02 |
Pluristem Ltd |
Methods for cell expansion and use of the thus produced cells and conditioned media for the therapy
|
US20090226909A1
(en)
|
2006-03-28 |
2009-09-10 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods and kits for Determining Predisposition to Warfarin Resistance
|
AU2007234733A1
(en)
*
|
2006-04-07 |
2007-10-18 |
The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Antibody compositions and methods for treatment of neoplastic disease
|
EA200870555A1
(en)
*
|
2006-05-19 |
2009-04-28 |
Тева Фармасьютикал Индастриз, Лтд. |
SLIP PROTEINS, THEIR APPLICATION AND METHODS OF THEIR PRODUCTION
|
US20070281883A1
(en)
*
|
2006-06-05 |
2007-12-06 |
Hanna Rosenfeld |
Development of follicle stimulating hormone agonists and antagonists in fish
|
WO2008010228A2
(en)
|
2006-07-20 |
2008-01-24 |
Yeda Research And Development Co. Ltd. |
Photosyntheticorganisms and compositions and methods of generating same
|
US8809052B2
(en)
|
2006-08-28 |
2014-08-19 |
Yeda Research And Development Co. Ltd. |
Methods of generating mature oligodendrocytes
|
ES2426754T3
(en)
|
2006-10-05 |
2013-10-25 |
Technion Research & Development Foundation Ltd. |
Microtubes and methods to produce them
|
US7888059B2
(en)
*
|
2006-10-05 |
2011-02-15 |
Yeda Research And Development Co. Ltd. |
Highly purified and stabilized Na,K-ATPase isoforms and methods of producing same
|
MX349479B
(en)
|
2006-12-20 |
2017-07-31 |
Evogene Ltd |
Polynucleotides and polypeptides involved in plant fiber development and methods of using same.
|
US7928083B2
(en)
*
|
2007-01-16 |
2011-04-19 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
H19 silencing nucleic acid agents for treating rheumatoid arthritis
|
US20100196403A1
(en)
*
|
2007-01-29 |
2010-08-05 |
Jacob Hochman |
Antibody conjugates for circumventing multi-drug resistance
|
EP2117616A2
(en)
|
2007-01-31 |
2009-11-18 |
Technion Research & Development Foundation Ltd. |
Electrospun scaffolds and methods of generating and using same
|
US8546333B2
(en)
|
2007-02-01 |
2013-10-01 |
Technion Research & Development Foundation Limited |
Albumin fibers and fabrics and methods of generating and using same
|
EP2134373A4
(en)
|
2007-02-28 |
2014-04-02 |
Yeda Res & Dev |
Nuclear targeting sequences
|
US20100158927A1
(en)
|
2007-03-29 |
2010-06-24 |
Technion Research & Development Foundation Ltd. |
Antibodies, methods and kits for diagnosing and treating melanoma
|
KR20100015774A
(en)
|
2007-04-02 |
2010-02-12 |
라모트 앳 텔-아비브 유니버시티 리미티드 |
Methods of detecting cancer cells and use of same for diagnosing and monitoring treatment of the disease
|
AU2008236316B2
(en)
|
2007-04-09 |
2013-05-02 |
Evogene Ltd. |
Polynucleotides, polypeptides and methods for increasing oil content, growth rate and biomass of plants
|
US9156865B2
(en)
|
2007-04-23 |
2015-10-13 |
Deliversir Ltd |
System for delivering therapeutic agents into living cells and cells nuclei
|
US9556210B2
(en)
|
2007-04-23 |
2017-01-31 |
Sabag-Rfa Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
WO2008129548A2
(en)
*
|
2007-04-23 |
2008-10-30 |
Segev Laboratories Limited |
A system for delivering therapeutic agents into living cells and cells nuclei
|
US8338113B2
(en)
|
2007-05-01 |
2012-12-25 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods for detecting fetal cells in the maternal blood
|
CN102847148A
(en)
|
2007-05-03 |
2013-01-02 |
新加坡科技研究局 |
Antibodies binding to an intracellular PRL-1 OR PRL-3 polypeptide
|
EP3366762B1
(en)
|
2007-05-07 |
2020-07-08 |
Protalix Ltd. |
Large scale disposable bioreactor
|
ATE540115T1
(en)
|
2007-07-11 |
2012-01-15 |
Yeda Res & Dev |
NUCLEIC ACID CONSTRUCT SYSTEMS WITH CAPABILITY TO DIAGNOSE OR TREAT A CELL CONDITION
|
JP2010533705A
(en)
|
2007-07-15 |
2010-10-28 |
ヒルマン,イチャク |
Disease treatment using antimicrobial peptides or their inhibitors
|
IL184627A0
(en)
|
2007-07-15 |
2008-12-29 |
Technion Res & Dev Foundation |
Agents for diagnosing and modulating metastasis and fibrosis as well as inflammation in a mammalian tissue
|
WO2009013750A2
(en)
|
2007-07-24 |
2009-01-29 |
Evogene Ltd. |
Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance and/or biomass and/or yield in plants expressing same
|
ES2534490T3
(en)
*
|
2007-08-02 |
2015-04-23 |
Gilead Biologics, Inc. |
LOX and LOXL2 inhibitors and uses thereof
|
MX2010001657A
(en)
|
2007-08-15 |
2010-03-15 |
Yeda Res & Dev |
Regulators of mmp-9 and uses therof.
|
AU2008299318A1
(en)
|
2007-09-12 |
2009-03-19 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
Methods of treating tumors in immune-privileged sites
|
US8529888B2
(en)
|
2007-09-19 |
2013-09-10 |
Pluristem Ltd. |
Adherent cells from adipose or placenta tissues and use thereof in therapy
|
US8088735B2
(en)
|
2007-10-19 |
2012-01-03 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof
|
EP2220112B1
(en)
|
2007-11-26 |
2015-08-26 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Compositions comprising fibrous polypeptides and polysaccharides
|
CN101977928B
(en)
|
2007-12-27 |
2014-12-10 |
伊沃基因有限公司 |
Isolated polypeptides, polynucleotides useful for modifying water user efficiency, fertilizer use efficiency, biotic/abiotic stress tolerance, yield and biomass in plants
|
WO2009095925A2
(en)
*
|
2008-01-31 |
2009-08-06 |
Compugen Ltd. |
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
|
US9297094B2
(en)
|
2008-02-21 |
2016-03-29 |
Technion Research & Development Foundation Ltd. |
Use of electrospun microtubes for drug delivery
|
US20110033473A1
(en)
*
|
2008-04-09 |
2011-02-10 |
Yoram Reiter |
Anti influenza antibodies and uses thereof
|
EP2280731A1
(en)
*
|
2008-04-09 |
2011-02-09 |
Technion Research and Development Foundation, Ltd. |
Anti human immunodeficiency antibodies and uses thereof
|
EP2508325A3
(en)
*
|
2008-04-10 |
2013-05-22 |
Objet Ltd. |
System and method for three dimensional model printing
|
ES2565185T3
(en)
|
2008-04-18 |
2016-04-01 |
Collplant Ltd. |
Methods of generation and use of procollagen
|
EP2268129B1
(en)
|
2008-04-21 |
2015-06-17 |
Danziger Innovations Ltd. |
Plant viral expression vectors and use of same for generating genotypic variations in plant genomes
|
SG176464A1
(en)
|
2008-05-09 |
2011-12-29 |
Agency Science Tech & Res |
Diagnosis and treatment of kawasaki disease
|
ES2674256T3
(en)
|
2008-05-22 |
2018-06-28 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides and methods of using them to increase plant yield
|
CA2725637A1
(en)
|
2008-05-27 |
2009-12-03 |
Pluristem Ltd. |
Methods of treating inflammatory colon diseases
|
US8663987B2
(en)
|
2008-05-28 |
2014-03-04 |
Ramot At Tel-Aviv University Ltd. |
Mesenchymal stem cells for the treatment of CNS diseases
|
US9952211B2
(en)
|
2008-06-29 |
2018-04-24 |
Realbio Technologies Ltd. |
Liquid-transfer device particularly useful as a capturing device in a biological assay process
|
JP5583667B2
(en)
|
2008-08-08 |
2014-09-03 |
ジェニスフィア・エルエルシー |
Long-acting DNA dendrimer and method thereof
|
GB2474807A
(en)
|
2008-08-08 |
2011-04-27 |
Agency Science Tech & Res |
Vhz for diagnosis and treatment of cancers
|
BR122021014165B1
(en)
|
2008-08-18 |
2022-08-16 |
Evogene Ltd. |
METHOD TO INCREASE NITROGEN USE EFFICIENCY, FERTILIZER USE EFFICIENCY, PRODUCTION, BIOMASS AND/OR NITROGEN DEFICIENCY AND DROUGHT STRESS TOLERANCE OF A PLANT, AND CONSTRUCTION OF ISOLATED NUCLEIC ACID
|
EP2334783B1
(en)
|
2008-09-02 |
2016-06-22 |
Pluristem Ltd. |
Adherent cells from placenta tissue and use thereof in therapy
|
US8367392B2
(en)
*
|
2008-09-05 |
2013-02-05 |
Transalgae Ltd. |
Genetic transformation of algal and cyanobacteria cells by microporation
|
EP2326340A4
(en)
|
2008-09-11 |
2013-01-23 |
Univ Ben Gurion |
Compositions and methods for treating s. pneumoniae infection
|
RU2535966C2
(en)
|
2008-09-12 |
2014-12-20 |
Криопрашис Криобиоложия Лтда. |
Cell-based therapy of ischemic tissue
|
KR101788284B1
(en)
|
2008-09-24 |
2017-10-19 |
텔 하쇼머 메디컬 리서치 인프라스트럭쳐 앤드 서비시스 리미티드. |
Peptides and compositions for prevention of cell adhesion and methods of using same
|
US20110178024A1
(en)
|
2008-09-29 |
2011-07-21 |
Ben Gurion University Of The Negev Research And Development Authority |
Amyloid beta-peptides and methods of use thereof
|
MX345298B
(en)
*
|
2008-10-30 |
2017-01-24 |
Evogene Ltd |
Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield.
|
WO2010055525A1
(en)
|
2008-11-17 |
2010-05-20 |
Technion Research & Development Foundation Ltd. |
Method for predicting a patient's responsiveness to anti-folate therapy
|
WO2010058396A1
(en)
|
2008-11-19 |
2010-05-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
A cd44vra antibody and diagnostic and therapeutic methods using same
|
WO2010061383A1
(en)
|
2008-11-26 |
2010-06-03 |
Biodalia Microbiological Technologies Ltd. |
A method of in-situ enrichment of foods with fructan
|
WO2010064231A1
(en)
|
2008-12-02 |
2010-06-10 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods of analyzing a-i rna editing and nucleic acid constructs capable of same
|
US20120014927A1
(en)
|
2008-12-03 |
2012-01-19 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods and kits for determining predisposition to cancer
|
ES2554765T3
(en)
|
2008-12-05 |
2015-12-23 |
Yeda Research And Development Co. Ltd. |
miRNA-9 or miRNA-9 * for use in the treatment of ALS
|
WO2010071610A1
(en)
|
2008-12-19 |
2010-06-24 |
Agency For Science, Technology And Research (A*Star) |
Severe chikungunya biomarkers
|
SG10201401054YA
(en)
|
2008-12-29 |
2014-07-30 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
Peptides and compositions for prevention of cell adhesion and methods of using same
|
WO2010076756A2
(en)
|
2008-12-29 |
2010-07-08 |
Evogene Ltd. |
Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance, biomass and/or yield in plants expressing same
|
EP2376653A2
(en)
|
2008-12-29 |
2011-10-19 |
Yissum Research Development Company of The Hebrew University of Jerusalem |
Methods of predicting responsiveness to interferon treatment and treating hepatitis c infection
|
WO2010076794A1
(en)
|
2008-12-31 |
2010-07-08 |
Technion Research & Development Foundation Ltd. |
Method of denitrifying brine and systems capable of same
|
US9107935B2
(en)
|
2009-01-06 |
2015-08-18 |
Gilead Biologics, Inc. |
Chemotherapeutic methods and compositions
|
IL196820A0
(en)
|
2009-02-01 |
2009-11-18 |
Yissum Res Dev Co |
Devitalized, acellular scaffold matrices derived from micro-organs seeded with various cells
|
CN102369015A
(en)
|
2009-02-02 |
2012-03-07 |
雷蒙特亚特特拉维夫大学有限公司 |
Peptides, pharmaceutical compositions comprising same and uses thereof
|
WO2010089707A1
(en)
|
2009-02-04 |
2010-08-12 |
Yeda Research And Development Co. Ltd. |
Methods and kits for determining sensitivity or resistance of prostate cancer to radiation therapy
|
US8828722B2
(en)
|
2009-02-26 |
2014-09-09 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Isolated populations of renal stem cells and methods of isolating and using same
|
LT3460062T
(en)
|
2009-03-02 |
2021-06-25 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics
|
PL2406279T3
(en)
|
2009-03-09 |
2016-07-29 |
Univ Ramot |
Compositions for prevention and treatment of neurodegenerative diseases
|
WO2010103517A1
(en)
|
2009-03-12 |
2010-09-16 |
Rappaport Family Institute For Research In The Medical Sciences |
Soluble compositions for the treatment of cxcr3-ligand associated diseases
|
US20120020954A1
(en)
|
2009-03-30 |
2012-01-26 |
Anat Achiron |
Methods of predicting clinical course and treating multiple sclerosis
|
MX2011010401A
(en)
|
2009-04-01 |
2012-01-20 |
Rappaport Family Inst Res In The Medical Sciences |
A method of regulating proliferation and differentiation of keratinocyes.
|
WO2010116375A1
(en)
|
2009-04-08 |
2010-10-14 |
Yeda Research And Development Co. Ltd. |
Isolated peptides for regulating apoptosis
|
BRPI1015350B1
(en)
|
2009-04-30 |
2021-08-24 |
Tel Hashomer Medical Research Infrastructure And Services Ltd |
HYBRIDOMA CELL, CEACAM1 ISOLATED ANTIBODY OR ANTIBODY FRAGMENT, METHOD FOR DIAGNOSING A CANCER IN A SUBJECT IN NEED OF THE SAME AND PHARMACEUTICAL COMPOSITION
|
CN102576024B
(en)
|
2009-05-19 |
2016-10-26 |
泽蒂克科技有限公司 |
The test kit of the differential staining of cervical cancer cell and/or tissue and method
|
EP2435072A2
(en)
|
2009-05-27 |
2012-04-04 |
Yeda Research and Development Co. Ltd. |
Proteasome inhibitors and uses thereof
|
WO2010137013A1
(en)
|
2009-05-27 |
2010-12-02 |
Ramot At Tel Aviv University Ltd. |
Crystallized photosystem i units from the pea plant and their use in solid state devices
|
US20120078163A1
(en)
|
2009-05-27 |
2012-03-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of generating connective tissue
|
WO2010137020A1
(en)
|
2009-05-28 |
2010-12-02 |
Yeda Research And Development Co. Ltd. |
Methods of treating inflammation
|
EP3626051A3
(en)
|
2009-06-10 |
2020-04-22 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance
|
CA2765779A1
(en)
|
2009-06-24 |
2010-12-29 |
Fund For Medical Research Development Of Infrastructure And Health Servi Ces - At Rambam Medical Center |
Methods and kits for isolating placental derived microparticles and use of same for diagnosis of fetal disorders
|
US9663778B2
(en)
|
2009-07-09 |
2017-05-30 |
OPKO Biologies Ltd. |
Long-acting coagulation factors and methods of producing same
|
WO2011004379A1
(en)
|
2009-07-10 |
2011-01-13 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Compositions and methods for treating cancer
|
WO2011010309A1
(en)
|
2009-07-21 |
2011-01-27 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
A method of diagnosing cancer
|
GB0913442D0
(en)
|
2009-07-31 |
2009-09-16 |
Univ Ramot |
Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof
|
US20120148546A1
(en)
|
2009-08-17 |
2012-06-14 |
Technion Research & Development Foundation Ltd. |
Pericyte progenitor cells and methods of generating and using same
|
CN102712683B
(en)
|
2009-08-21 |
2014-09-10 |
吉联亚生物科技有限公司 |
Catalytic domains from lysyl oxidase and LOXL2
|
CN102481311A
(en)
|
2009-08-21 |
2012-05-30 |
比欧洛吉科斯公司 |
Preventing and curing beneficial insect diseases via plant transcribed molecules
|
EP2467714A4
(en)
*
|
2009-08-21 |
2013-02-20 |
Gilead Biologics Inc |
In vitro screening assays
|
WO2011024172A2
(en)
|
2009-08-27 |
2011-03-03 |
Technion Research & Development Foundation Ltd. |
Liposomal compositions and uses of same
|
WO2011030332A2
(en)
|
2009-09-08 |
2011-03-17 |
Yeda Research And Development Co. Ltd. |
Methods for hematopoietic precursor mobilization
|
EP2475784A1
(en)
|
2009-09-08 |
2012-07-18 |
Ramot at Tel-Aviv University Ltd. |
Methods of diagnosing amyotrophic lateral sclerosis (als)
|
US20120171213A1
(en)
|
2009-09-10 |
2012-07-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of treating tumors
|
BR112012006005A2
(en)
|
2009-09-17 |
2017-09-19 |
Univ Ramot |
"peptides in the treatment of oxidative stress disorder"
|
WO2011033506A2
(en)
|
2009-09-17 |
2011-03-24 |
Yeda Research And Development Co. Ltd. |
Isolated pon1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
US8735124B2
(en)
|
2009-09-17 |
2014-05-27 |
Yeda Research And Development Co. Ltd. |
Isolated PON1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
US20110081706A1
(en)
*
|
2009-10-02 |
2011-04-07 |
TransAlgae Ltd |
Method and system for efficient harvesting of microalgae and cyanobacteria
|
CN105368836A
(en)
|
2009-10-14 |
2016-03-02 |
耶路撒冷希伯来大学伊森姆研究发展公司 |
Compositions for controlling varroa mites in bees
|
US8962584B2
(en)
|
2009-10-14 |
2015-02-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Compositions for controlling Varroa mites in bees
|
JP2013508013A
(en)
|
2009-10-16 |
2013-03-07 |
ザ ユニバーシティ オブ メディスン アンド デンティストリー オブ ニュー ジャージー |
Method of treating chronic neural tissue injury using cell therapy strategy
|
US9476060B2
(en)
|
2009-10-21 |
2016-10-25 |
Danziger Innovations Ltd. |
Generating genotypic variations in plant genomes by gamete infection
|
IL201999A
(en)
|
2009-11-08 |
2017-10-31 |
Medical Res & Development Fund For Health Services Bnai Zion Medical Center The State Of Israel |
Knock-out mouse of the mo-1 gene, a gene associated with morbid obesity
|
CA3174901A1
(en)
|
2009-11-12 |
2011-05-19 |
Technion Research & Development Foundation Ltd. |
Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
|
US8962561B2
(en)
|
2009-11-12 |
2015-02-24 |
Ramot At Tel-Aviv University Ltd. |
Compositions comprising PEDF and uses of same in the treatment and prevention of ovary-related syndromes
|
WO2011058555A1
(en)
|
2009-11-12 |
2011-05-19 |
Yeda Research And Development Co. Ltd. |
A method of editing dna in a cell and constructs capable of same
|
WO2011061736A1
(en)
|
2009-11-17 |
2011-05-26 |
Protalix Ltd. |
Alkaline alpha galactosidase for the treatment of fabry disease
|
US20120273993A1
(en)
|
2009-11-24 |
2012-11-01 |
Collplant Ltd. |
Method of generating collagen fibers
|
CN102639692B
(en)
|
2009-11-30 |
2015-02-04 |
普拉里斯坦有限公司 |
Adherent cells from placenta and use of same in disease treatment
|
WO2011067745A2
(en)
|
2009-12-06 |
2011-06-09 |
Rosetta Green Ltd. |
Compositions and methods for enhancing plants resistance to abiotic stress
|
WO2011072091A1
(en)
|
2009-12-09 |
2011-06-16 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for treating diseases, disorders or injury of the cns
|
EP2519097B1
(en)
|
2009-12-28 |
2016-03-02 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency
|
ES2851601T3
(en)
|
2009-12-29 |
2021-09-08 |
Gamida Cell Ltd |
Methods to enhance the proliferation and activity of natural killer cells
|
WO2011083464A2
(en)
|
2010-01-05 |
2011-07-14 |
Vascular Biogenics Ltd. |
Methods for use of a specific anti-angiogenic adenoviral agent
|
SG10201500015TA
(en)
|
2010-01-12 |
2015-02-27 |
Vascular Biogenics Ltd |
Methods of producing adenovirus vectors and viral preparations generated thereby
|
CA2787311C
(en)
|
2010-01-27 |
2017-08-15 |
Yeda Research And Development Co. Ltd. |
Antibodies that inhibit metalloproteins
|
CN103370080A
(en)
|
2010-02-04 |
2013-10-23 |
吉联亚生物科技有限公司 |
Antibodies that bind to lysyl oxidase-like 2 (LOXL2) and methods of use therefor
|
US9410131B2
(en)
|
2010-02-11 |
2016-08-09 |
Yeda Research And Development Co. Ltd. |
Enzymatic systems for carbon fixation and methods of generating same
|
US20130109615A1
(en)
|
2010-02-24 |
2013-05-02 |
Ben Gurion University Of The Negev Research And Development Authority |
Methods for inhibiting necrosis
|
WO2011107939A1
(en)
|
2010-03-01 |
2011-09-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of predicting efficacy of an anti-vegfa treatment for solid tumors
|
WO2011107994A1
(en)
|
2010-03-04 |
2011-09-09 |
Yeda Research And Development Co. Ltd. |
Methods of measuring protein stability
|
JP5925701B2
(en)
|
2010-03-08 |
2016-05-25 |
モンサント テクノロジー エルエルシー |
Polynucleotide molecules for gene regulation in plants
|
EP2545176B1
(en)
|
2010-03-08 |
2016-05-11 |
Yeda Research and Development Co. Ltd. |
Recombinant protein production in heterologous systems
|
US20120329089A1
(en)
|
2010-03-11 |
2012-12-27 |
Jacob Edrei |
Methods of generating hydrogen
|
EP2556085A2
(en)
|
2010-04-05 |
2013-02-13 |
Bar-Ilan University |
Protease-activatable pore-forming polypeptides
|
US9458438B2
(en)
|
2010-04-12 |
2016-10-04 |
Ben Gurion University Of The Negev Research And Development Authority |
Sulfotransferase of a red microalga and uses thereof
|
WO2011128897A1
(en)
|
2010-04-12 |
2011-10-20 |
Technion Research & Development Foundation Ltd. |
Populations of pancreatic progenitor cells and methods of isolating and using same
|
KR20130105782A
(en)
|
2010-04-18 |
2013-09-26 |
예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 |
Molecules and methods of using same for treating erbb/erbb ligands associated diseases
|
BR122021002337B1
(en)
|
2010-04-28 |
2022-03-22 |
Evogene Ltd |
Method of increasing yield, biomass, growth rate, vigor, oil content, fiber yield fiber quality, abiotic stress tolerance and/or nitrogen use efficiency of a plant, and isolated nucleic acid construct
|
US20130053277A1
(en)
|
2010-05-04 |
2013-02-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of identifying inhibitors of polypeptides-of-interest
|
EP2566500B1
(en)
|
2010-05-05 |
2017-04-12 |
Rappaport Family Institute for Research in the Medical Sciences |
Ccl1 for use in therapy
|
IL208820A0
(en)
|
2010-10-19 |
2011-01-31 |
Rachel Teitelbaum |
Biologic female contraceptives
|
EP2569417B1
(en)
|
2010-05-13 |
2018-04-18 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Isolated populations of adult renal cells and methods of isolating and using same
|
DK2390664T3
(en)
|
2010-05-25 |
2013-07-22 |
Fraunhofer Ges Forschung |
Method for Electrochemical Detection of Binding Reactions
|
AU2011258173B2
(en)
|
2010-05-26 |
2014-07-03 |
The Board Of Trustees Of The University Of Illinois |
Personal glucose meters for detection and quantification of a broad range of analytes
|
WO2011151833A1
(en)
|
2010-06-03 |
2011-12-08 |
Ramot At Tel-Aviv University Ltd. |
Methods of treating diabetes and compositions capable of same
|
AU2011263306A1
(en)
|
2010-06-07 |
2013-01-10 |
Osnat Ashur-Fabian |
Methods and kits for diagnosing conditions related to hypoxia
|
US9187787B2
(en)
|
2010-06-16 |
2015-11-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of diagnosing and treating cancer
|
US20130097731A1
(en)
|
2010-06-16 |
2013-04-18 |
Futuragene Israel Ltd. |
Pest-resistant plants containing a combination of a spider toxin and a chitinase
|
ES2817780T3
(en)
|
2010-07-12 |
2021-04-08 |
The State Of Israel Ministry Of Agriculture And Rural Development Agricultural Res Organization A R |
Isolated polynucleotides and methods and plants that use them to regulate the acidity of plants
|
WO2012007950A2
(en)
|
2010-07-15 |
2012-01-19 |
Technion Research & Development Foundation Ltd. |
Isolated high affinity entities with t-cell receptor like specificity towards native complexes of mhc class ii and diabetes-associated autoantigenic peptides
|
EP2593551B1
(en)
|
2010-07-15 |
2016-09-14 |
Technion Research & Development Foundation Ltd. |
Isolated high affinity entities with t-cell receptor like specificity towards native complexes of mhc class ii and glutamic acid decarboxylase (gad) autoantigenic peptides
|
WO2012007919A2
(en)
|
2010-07-15 |
2012-01-19 |
Technion Research & Development Foundation Ltd. |
Nucleic acid construct for increasing abiotic stress tolerance in plants
|
US9624469B2
(en)
|
2010-07-22 |
2017-04-18 |
Cellect Biotherapeutics Ltd. |
Regulatory immune cells with enhanced targeted cell death effect
|
US20130130311A1
(en)
|
2010-07-27 |
2013-05-23 |
Yeda Research And Development Co., Ltd. |
Methods and systems for assessing clonality of cell cultures
|
US9144585B2
(en)
|
2010-07-27 |
2015-09-29 |
Technion Research & Development Foundation Limited |
Isolated mesenchymal progenitor cells and extracellular matrix produced thereby
|
JP2013535966A
(en)
|
2010-07-27 |
2013-09-19 |
テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド |
Method for generating induced pluripotent stem cells from keratinocytes derived from extracted hair follicles
|
US8901074B2
(en)
|
2010-08-04 |
2014-12-02 |
Ramot At Tel-Aviv University |
Methods of treating autoimmune diseases of the central nervous system (CNS) and neurodegenerative diseases
|
EP2606122A1
(en)
|
2010-08-22 |
2013-06-26 |
Ramot at Tel Aviv University, Ltd. |
Induced pluripotent stem cells derived from human pancreatic beta cells
|
WO2012025925A1
(en)
|
2010-08-24 |
2012-03-01 |
Rappaport Family Institute For Research In The Medical Sciences |
Methods of improving transplantation using sdf-1alpha
|
MX365161B
(en)
|
2010-08-30 |
2019-05-24 |
Evogene Ltd |
Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance.
|
EP2614141B1
(en)
|
2010-09-07 |
2019-07-31 |
Technion Research & Development Foundation Limited |
Novel methods and culture media for culturing pluripotent stem cells
|
US20130164288A1
(en)
|
2010-09-07 |
2013-06-27 |
Protalix Ltd. |
Readthrough acetylcholinesterase (ache-r) for treating or preventing parkinson's disease
|
WO2012032519A2
(en)
|
2010-09-07 |
2012-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of diagnosing parkinson's disease
|
WO2012032510A1
(en)
|
2010-09-07 |
2012-03-15 |
Yeda Research And Development Co. Ltd. |
Primers for amplifying dna and methods of selecting same
|
SG188471A1
(en)
|
2010-09-08 |
2013-04-30 |
Yeda Res & Dev |
An immunosuppressive drug combination for a stable and long term engraftment
|
PT2613801T
(en)
|
2010-09-08 |
2016-09-12 |
Yeda Res & Dev |
Use of anti third party central memory t cells for anti-leukemia/lymphoma treatment
|
CN103210082A
(en)
|
2010-09-15 |
2013-07-17 |
雷蒙特亚特特拉维夫大学有限公司 |
Methods of expanding and redifferentiating islet beta cells
|
WO2012038956A1
(en)
|
2010-09-20 |
2012-03-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of treating neurodegenerative diseases
|
WO2012052872A2
(en)
|
2010-10-17 |
2012-04-26 |
Yeda Research And Development Co. Ltd. |
Methods and compositions for the treatment of insulin-associated medical conditions
|
WO2012052878A1
(en)
|
2010-10-19 |
2012-04-26 |
Vascular Biogenics Ltd. |
Isolated polynucleotides and nucleic acid constructs for directing expression of a gene-of-interest in cells
|
US20130216603A1
(en)
|
2010-10-27 |
2013-08-22 |
Nanocyte (Israel) Ltd. |
Pharmaceutical compositions and delivery devices comprising stinging cells or capsules
|
US10066024B2
(en)
|
2010-10-28 |
2018-09-04 |
Yeda Research And Development Co. Ltd. |
Methods of generating antibodies to metalloenzymes
|
WO2012059922A2
(en)
|
2010-11-03 |
2012-05-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Transgenic plants with improved saccharification yields and methods of generating same
|
US9410132B2
(en)
|
2010-11-04 |
2016-08-09 |
Ben-Gurion University Of The Negev Research And Development Authority |
Acyl-CoA: diacylglycerol acyltransferase 1-like gene (PtDGAT1) and uses thereof
|
TW201225972A
(en)
|
2010-11-15 |
2012-07-01 |
Univ Ramot |
Dipeptide analogs for treating conditions associated with amyloid fibril formation
|
US10117895B2
(en)
|
2010-11-17 |
2018-11-06 |
Ben-Gurion University Of The Negev Research And Development Authority |
T-cell therapy to neurodegenerative diseases
|
JP6139410B2
(en)
|
2010-12-02 |
2017-05-31 |
テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド |
Method for producing corneal cell and cell population containing the corneal cell
|
US20120183960A1
(en)
|
2010-12-07 |
2012-07-19 |
Enterologics, Inc. |
Method for identifying e. coli m-17
|
JP5922147B2
(en)
|
2010-12-15 |
2016-05-24 |
カディマステム リミテッド |
Insulin-producing cells derived from pluripotent stem cells
|
US9551006B2
(en)
|
2010-12-22 |
2017-01-24 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for improving plant properties
|
KR101947126B1
(en)
|
2010-12-28 |
2019-02-13 |
카메디스 리미티드 |
Plant extracts for the treatment and prevention of infections
|
JP5913372B2
(en)
|
2011-01-20 |
2016-04-27 |
プロタリクス リミテッド |
Nucleic acid expression constructs for the expression of α-galactosidase in plants and plant cells
|
US20130316358A1
(en)
|
2011-01-31 |
2013-11-28 |
Yeda Research And Development Co. Ltd. |
Methods of diagnosing disease using overlap extension pcr
|
US20130330349A1
(en)
|
2011-02-23 |
2013-12-12 |
Rappaport Family Institute For Research In The Medical Sciences |
High affinity molecules capable of binding a type a plexin receptor and uses of same
|
CN106978437A
(en)
|
2011-03-02 |
2017-07-25 |
富途锐基尼以色列有限公司 |
The antibiotic property genetically modified plants of T3SS albumen with functional disturbance
|
WO2012117373A1
(en)
|
2011-03-03 |
2012-09-07 |
Ramot At Tel-Aviv University Ltd. |
Genetically modified muscle cells which express neurotrophic factors
|
AU2012226398B9
(en)
|
2011-03-06 |
2017-04-13 |
Merck Serono S.A. |
Low fucose cell lines and uses thereof
|
WO2012120518A1
(en)
|
2011-03-08 |
2012-09-13 |
Ramot At Tel-Aviv University Ltd. |
Compositions and methods for diagnosing and treating phenylketonuria (pku)
|
IN2013MN01438A
(en)
|
2011-03-17 |
2015-06-12 |
Univ Ramot |
|
WO2012123938A1
(en)
|
2011-03-17 |
2012-09-20 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Quinolone analogs for treating autoimmune diseases
|
EP3260533B1
(en)
|
2011-03-22 |
2019-09-11 |
Pluristem Ltd. |
Methods for treating radiation or chemical injury
|
MX2013010910A
(en)
|
2011-03-24 |
2014-03-27 |
Neurim Pharma 1991 |
Neuroprotective peptides.
|
WO2012131680A2
(en)
|
2011-03-28 |
2012-10-04 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for treating inflammation
|
WO2012137202A1
(en)
|
2011-04-05 |
2012-10-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Composition comprising an iron indicator attached to a microparticle and uses of same for quantifying non-transferrin bound iron (ntbi) and cellular labile iron (lci)
|
BR112013025782B1
(en)
|
2011-04-06 |
2022-09-06 |
Ramot At Tel-Aviv University Ltd |
METHOD OF MEASUREMENT OF A METABOLIC ACTIVITY (AM) OF A CELL, EX-VIVO METHOD OF DIAGNOSIS OF A DISEASE ASSOCIATED WITH A MODIFIED METABOLIC ACTIVITY IN AN INDIVIDUAL IN RESPECTIVE NEED, EX-VIVO METHOD OF OPTIMIZATION OF THE TREATMENT OF A DISEASE, EX METHOD - VIVO MONITORING OF TREATMENT OF A DISEASE IN AN INDIVIDUAL AND EX-VIVO METHOD OF IDENTIFICATION OF AN AGENT CAPABLE OF CHANGING A METABOLIC ACTIVITY OF CELLS
|
US9150644B2
(en)
|
2011-04-12 |
2015-10-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II
|
CN108342350A
(en)
|
2011-04-15 |
2018-07-31 |
普拉里斯坦有限公司 |
Harvest the method and system of cell
|
CA2834027C
(en)
|
2011-05-03 |
2021-12-21 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency
|
US9192670B2
(en)
|
2011-05-04 |
2015-11-24 |
Ramot At Tel-Aviv University Ltd. |
Regulation of amyloid beta molecular composition for the treatment of alzheimer's disease
|
WO2012153333A1
(en)
|
2011-05-09 |
2012-11-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Regeneration and repair of mesenchymal tissue using amelogenin
|
WO2012153336A2
(en)
|
2011-05-12 |
2012-11-15 |
Rakuto Bio Technologies Ltd. |
Methods and device for lightening skin complexion
|
WO2012156976A1
(en)
|
2011-05-16 |
2012-11-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of producing artemisinin in non-host plants and vectors for use in same
|
WO2012160526A2
(en)
|
2011-05-23 |
2012-11-29 |
Ofir Menashe |
Formulations of microorganism comprising particles and uses of same
|
EP3263127B1
(en)
|
2011-05-23 |
2019-08-21 |
Yeda Research and Development Co. Ltd |
Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
|
CN104039812A
(en)
|
2011-05-31 |
2014-09-10 |
和黄生物膜医疗解决方案有限公司 |
Dispersion and detachment of cell aggregates
|
WO2012164565A1
(en)
|
2011-06-01 |
2012-12-06 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for downregulating prokaryotic genes
|
US10166295B2
(en)
|
2011-06-02 |
2019-01-01 |
Opko Biologics Ltd. |
Pegylated OXM variants
|
WO2012172555A1
(en)
|
2011-06-14 |
2012-12-20 |
Yeda Research And Development Co. Ltd. |
Combination therapy to prevent dcis formation and progression to breast cancer
|
BR112013033096A2
(en)
|
2011-06-23 |
2017-01-24 |
Kaiima Bio Agritech Ltd |
common wheat, plants or parts thereof having partially or fully multiplied genomes, hybrids and their products, and their methods of generation and use
|
CN103929950A
(en)
|
2011-07-20 |
2014-07-16 |
凯伊玛生物农业科技有限公司 |
Maize plants having a partially or fully multiplied genome and uses thereof
|
EP2550982A1
(en)
|
2011-07-27 |
2013-01-30 |
Technion Research & Development Foundation Ltd. |
Devices for surgical applications
|
CN104039960B
(en)
|
2011-08-04 |
2017-05-10 |
耶达研究及发展有限公司 |
Micro-rnas and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions
|
WO2013021389A2
(en)
|
2011-08-09 |
2013-02-14 |
Yeda Research And Development Co.Ltd. |
Downregulation of mir-7 for promotion of beta cell differentiation and insulin production
|
WO2013024481A1
(en)
|
2011-08-14 |
2013-02-21 |
Kaiima Bio Agritech Ltd. |
Durum wheat plants having a partially or fully multiplied genome and uses thereof
|
WO2013035070A1
(en)
|
2011-09-07 |
2013-03-14 |
Yeda Research And Development Co. Ltd. |
Olfactory signature and odorant mixture having the same
|
US20140248293A1
(en)
|
2011-09-08 |
2014-09-04 |
Yeda Research And Development Co., Ltd |
Novel risk biomarkers for lung cancer
|
WO2013035099A1
(en)
|
2011-09-08 |
2013-03-14 |
Yeda Research And Development Co. Ltd. |
Anti third party central memory t cells, methods of producing same and use of same in transplantation and disease treatment
|
CN109997852A
(en)
|
2011-09-13 |
2019-07-12 |
孟山都技术公司 |
Method and composition for Weeds distribution
|
US10829828B2
(en)
|
2011-09-13 |
2020-11-10 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
MX343072B
(en)
|
2011-09-13 |
2016-10-21 |
Monsanto Technology Llc |
Methods and compositions for weed control.
|
US10806146B2
(en)
|
2011-09-13 |
2020-10-20 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
UA116089C2
(en)
|
2011-09-13 |
2018-02-12 |
Монсанто Текнолоджи Ллс |
Methods and compositios for weed control
|
AU2012308686B2
(en)
|
2011-09-13 |
2018-05-10 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10760086B2
(en)
|
2011-09-13 |
2020-09-01 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
WO2013054320A1
(en)
|
2011-10-11 |
2013-04-18 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam)
|
PT2768851T
(en)
|
2011-10-21 |
2017-09-08 |
Augurex Life Sciences Corp |
Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis
|
WO2013061328A2
(en)
|
2011-10-27 |
2013-05-02 |
Yeda Research And Development Co. Ltd. |
Method of treating cancer
|
CA2851296C
(en)
|
2011-11-03 |
2020-08-25 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for neuroprotection
|
EP2776565A1
(en)
|
2011-11-08 |
2014-09-17 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for treating diseases, disorders or injury of the nervous system
|
WO2013076729A1
(en)
|
2011-11-23 |
2013-05-30 |
Danziger Dan Flower Farm |
Otomeria plants
|
US9617331B2
(en)
|
2011-11-27 |
2017-04-11 |
Yeda Research And Development Co. Ltd. |
Methods of regulating angiogenesis by administering agents which increase apoB-100 polypeptide
|
PL2788009T3
(en)
|
2011-12-08 |
2016-11-30 |
|
Mammalian fetal pulmonary cells and therapeutic use of same
|
WO2013093921A1
(en)
|
2011-12-20 |
2013-06-27 |
Collplant Ltd. |
Collagen coated synthetic polymer fibers
|
CN105833925B
(en)
|
2011-12-22 |
2018-11-13 |
瑞尔比奥技术有限公司 |
sequential lateral flow capillary device for analyte determination
|
US10434121B2
(en)
|
2011-12-22 |
2019-10-08 |
Yeda Research And Development Co. Ltd. |
Combination therapy for a stable and long term engraftment using specific protocols for T/B cell depletion
|
US20150013029A1
(en)
|
2011-12-28 |
2015-01-08 |
Kaiima Bio Agritech Ltd. |
Cultivated sorghum plant having a partially or fully multiplied genome and uses of same
|
WO2013098813A1
(en)
|
2012-01-01 |
2013-07-04 |
Qbi Enterprises Ltd. |
Endo180-targeted particles for selective delivery of therapeutic and diagnostic agents
|
WO2013114363A2
(en)
|
2012-01-30 |
2013-08-08 |
Yeda Research And Development Co.Ltd. |
Antimicrobial agents
|
US9603906B2
(en)
|
2012-02-01 |
2017-03-28 |
Protalix Ltd. |
Inhalable liquid formulations of DNase I
|
WO2013118120A2
(en)
|
2012-02-06 |
2013-08-15 |
Rosetta Green Ltd. |
Isolated polynucleotides expressing or modulating micrornas or targets of same, transgenic plants comprising same and uses thereof in improving nitrogen use efficiency, abiotic stress tolerance, biomass, vigor or yield of a plant
|
CA2863795A1
(en)
|
2012-02-13 |
2013-08-22 |
Gamida-Cell Ltd. |
Culturing of mesenchymal stem cells
|
JP6242819B2
(en)
|
2012-02-14 |
2017-12-06 |
オプコ バイオロジクス リミテッド |
Long-acting coagulation factor and method for producing the same
|
AU2013220005A1
(en)
|
2012-02-19 |
2014-09-04 |
Protalix Ltd. |
Oral unit dosage forms and uses of same for the treatment of Gaucher disease
|
WO2013124816A2
(en)
|
2012-02-22 |
2013-08-29 |
Brainstem Biotec Ltd. |
Generation of neural stem cells and motor neurons
|
US10034902B2
(en)
|
2012-02-22 |
2018-07-31 |
Exostem Biotec Ltd. |
MicroRNAs for the generation of astrocytes
|
WO2013128454A1
(en)
|
2012-03-01 |
2013-09-06 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), Volcani Center |
Male sterile garlic plants, hybrid offspring of same and methods of generating and using same
|
EP3483184A1
(en)
|
2012-03-07 |
2019-05-15 |
Yeda Research and Development Co. Ltd |
Compositions for inhibition of quiescinsulfhydryl oxidase (qsox1) and uses of same
|
WO2013140389A1
(en)
|
2012-03-22 |
2013-09-26 |
Ramot At Tel-Aviv University Ltd. |
Plif multimeric peptides and uses thereof
|
CA2868238A1
(en)
|
2012-04-18 |
2013-10-24 |
Ramot At Tel Aviv University Ltd. |
Lipidated glycosaminoglycan particles for the delivery of nucleic acids
|
PE20142405A1
(en)
|
2012-04-19 |
2015-01-25 |
Opko Biolog Ltd |
LONG-ACTING OXYTOMODULIN VARIANTS AND METHODS OF PRODUCING THEM
|
EP2841084B1
(en)
|
2012-04-24 |
2018-05-30 |
Biokine Therapeutics Ltd. |
Cxcr4 antagonist peptide for use in the treatment of large cell lung cancer
|
EP2846819B1
(en)
|
2012-05-09 |
2017-05-03 |
Yeda Research and Development Co. Ltd. |
Variants of tace pro-domain as tnf-a inhibitor and their medical use
|
US8865158B2
(en)
|
2012-05-22 |
2014-10-21 |
Ramot At Tel-Aviv University Ltd. |
Bacteriophages for reducing toxicity of bacteria
|
CN104619843B
(en)
|
2012-05-24 |
2020-03-06 |
A.B.种子有限公司 |
Compositions and methods for silencing gene expression
|
IN2014KN02831A
(en)
|
2012-05-24 |
2015-05-08 |
Mountgate Group Ltd |
|
WO2013183048A1
(en)
|
2012-06-03 |
2013-12-12 |
Ben-Gurion University Of The Negev Research And Development Authority |
Functionalized titanium binding peptides and implants coated with same
|
IN2015DN00003A
(en)
|
2012-06-04 |
2015-05-22 |
Opko Biolog Ltd |
|
WO2014006621A1
(en)
|
2012-07-03 |
2014-01-09 |
Nanospun Technologies Ltd. |
Methods and devices for adsorption and biodegradation of petroleum
|
US9567569B2
(en)
|
2012-07-23 |
2017-02-14 |
Gamida Cell Ltd. |
Methods of culturing and expanding mesenchymal stem cells
|
US9175266B2
(en)
|
2012-07-23 |
2015-11-03 |
Gamida Cell Ltd. |
Enhancement of natural killer (NK) cell proliferation and activity
|
EP2880155B1
(en)
|
2012-07-29 |
2019-04-17 |
Yeda Research and Development Co., Ltd. |
Use of the reductive glycine pathway for generating formatotrophic and autotrophic microorganisms
|
JP6340366B2
(en)
|
2012-07-31 |
2018-06-06 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
Methods for diagnosing and treating motor neuron disease
|
BR112015001435B1
(en)
|
2012-08-06 |
2022-01-18 |
Brainstorm Cell Therapeutics Ltd |
METHODS FOR GENERATION OF CELLS THAT SECRET BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF), GLIA-DERIVED NEUROTROPHIC FACTOR (GDNF), HEPATOCYTE GROWTH FACTOR (HGF) AND VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) IN WHICH THESE CELLS DO NOT SECRET FACTOR NERVE GROWTH (NGF)
|
WO2014033723A1
(en)
|
2012-09-03 |
2014-03-06 |
A.B. Seeds Ltd. |
Method of improving abiotic stress tolerance of plants and plants generated thereby
|
EP2895197B1
(en)
|
2012-09-12 |
2020-02-26 |
Ramot at Tel-Aviv University Ltd. |
Immunoparticles and methods of generating and using same
|
WO2014057490A1
(en)
|
2012-10-09 |
2014-04-17 |
Ramot At Tel-Aviv University Ltd. |
Methods and kits for predicting prognosis of cancer using soluble mortalin in blood
|
AU2013336237A1
(en)
|
2012-10-22 |
2015-06-11 |
Sabag-Rfa Ltd |
A system for delivering therapeutic agents into living cells and cells nuclei
|
EP2912062A1
(en)
|
2012-10-24 |
2015-09-02 |
Yeda Research and Development Co. Ltd. |
Combinations of epidermal growth factor receptor targeting antibodies for treating cancer
|
WO2014068553A1
(en)
|
2012-10-29 |
2014-05-08 |
Yeda Research And Development Co. Ltd. |
Aptamers, multimeric aptamers and uses thereof
|
ES2882890T3
(en)
|
2012-11-20 |
2021-12-03 |
Opko Biologics Ltd |
Method for increasing the hydrodynamic volume of polypeptides by binding to carboxy terminal peptides of gonadotrophin
|
CA2877847A1
(en)
|
2012-11-29 |
2014-06-05 |
Yeda Research And Development Co. Ltd. |
Methods of preventing tumor metastasis, treating and prognosing cancer and identifying agents which are putative metastasis inhibitors
|
US10683505B2
(en)
|
2013-01-01 |
2020-06-16 |
Monsanto Technology Llc |
Methods of introducing dsRNA to plant seeds for modulating gene expression
|
EP2941488B1
(en)
|
2013-01-01 |
2023-03-22 |
Monsanto Technology LLC |
Methods of introducing dsrna to plant seeds for modulating gene expression
|
WO2014108850A2
(en)
|
2013-01-09 |
2014-07-17 |
Yeda Research And Development Co. Ltd. |
High throughput transcriptome analysis
|
WO2014108854A1
(en)
|
2013-01-09 |
2014-07-17 |
Fusimab Ltd. |
Monospecific anti-hgf and anti-ang2 antibodies and bispecific anti-hgf/anti-ang2 antibodies
|
ES2681425T3
(en)
|
2013-01-17 |
2018-09-13 |
Novellusdx Ltd. |
Methods and systems for the identification of specific conductive mutations
|
WO2014118785A1
(en)
|
2013-02-04 |
2014-08-07 |
Ramot At Tel-Aviv University Ltd. |
Generation of cytotoxic tumor specific cell lines and uses thereof
|
AU2014224174B2
(en)
|
2013-03-06 |
2018-08-30 |
Hadasit Medical Research Services And Development Ltd. |
Use of plant cells expressing a TNFalpha polypeptide inhibitor in therapy
|
US20160017021A1
(en)
|
2013-03-06 |
2016-01-21 |
Protalix Ltd. |
TNF alpha INHIBITOR POLYPEPTIDES, POLYNUCLEOTIDES ENCODING SAME, CELLS EXPRESSING SAME AND METHODS OF PRODUCING SAME
|
BR112015023051A2
(en)
|
2013-03-13 |
2017-11-14 |
Monsanto Technology Llc |
weed control method, herbicidal composition, microbial expression cassette and polynucleotide production method
|
UY35385A
(en)
|
2013-03-13 |
2014-09-30 |
Monsanto Technology Llc |
? METHODS AND COMPOSITIONS FOR WEED CONTROL ?.
|
US10568328B2
(en)
|
2013-03-15 |
2020-02-25 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
CA2907680A1
(en)
|
2013-03-21 |
2014-09-25 |
Collplant Ltd. |
Compositions comprising collagen and prp for tissue regeneration
|
MX363896B
(en)
|
2013-03-24 |
2019-04-05 |
Biokine Therapeutics Ltd |
Methods of treating myeloid leukemia.
|
CN105377289A
(en)
|
2013-04-21 |
2016-03-02 |
耶达研究及发展有限公司 |
Agents for downregulation of the activity and/or amount of bcl-xL and/or Bcl-w
|
US10920192B2
(en)
|
2013-04-23 |
2021-02-16 |
Yeda Research And Development Co. Ltd. |
Isolated naive pluripotent stem cells and methods of generating same
|
EP2989119B1
(en)
|
2013-04-25 |
2018-03-21 |
Yeda Research and Development Co., Ltd. |
Use of inhibitory peptides for the treatment of inflammatory diseases
|
US20160115231A1
(en)
|
2013-05-21 |
2016-04-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Treatment of mast cell related pathologies
|
MX368498B
(en)
|
2013-05-27 |
2019-10-04 |
Rakuto Bio Tech Ltd |
Enzymatic system-containing cosmetic compositions.
|
ES2938044T3
(en)
|
2013-06-24 |
2023-04-04 |
Univ Ramot |
Omentum-based structure and delivery system
|
US9850496B2
(en)
|
2013-07-19 |
2017-12-26 |
Monsanto Technology Llc |
Compositions and methods for controlling Leptinotarsa
|
JP6668236B2
(en)
|
2013-07-19 |
2020-03-18 |
モンサント テクノロジー エルエルシー |
Composition for controlling LEPTINOTARSA and method therefor
|
WO2015015489A1
(en)
|
2013-07-30 |
2015-02-05 |
Biolinerx Ltd. |
Antibody for treating diabetes and autoimmune diseases
|
EP3039030B1
(en)
|
2013-08-29 |
2018-09-19 |
Yeda Research and Development Co. Ltd. |
Selective inhibitors of alpha2 isoform of na,k-atpase and use for reduction of intra-ocular pressure
|
WO2015033343A1
(en)
|
2013-09-03 |
2015-03-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Compositions and methods for expressing recombinant polypeptides
|
IL228284A
(en)
|
2013-09-03 |
2016-12-29 |
Technion Res & Dev Foundation |
Implants composed of cellular scaffolds and a vascular pedicle
|
WO2015033344A1
(en)
|
2013-09-05 |
2015-03-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods and kits for inhibiting pathogenicity of group a streptococcus (gas) or group g streptococcus (ggs)
|
WO2015037009A1
(en)
|
2013-09-16 |
2015-03-19 |
Plexicure Ltd. |
Isolated proteins capable of binding plexin-a4 and methods of producing and using same
|
WO2015040609A1
(en)
|
2013-09-17 |
2015-03-26 |
Yeda Research And Development Co. Ltd. |
Erk-derived peptides and uses thereof
|
AU2014330807B2
(en)
|
2013-10-01 |
2020-07-02 |
Kadimastem Ltd. |
Directed differentiation of astrocytes from human pluripotent stem cells for use in drug screening and the treatment of Amyotrophic Lateral Sclerosis (ALS)
|
KR102444140B1
(en)
|
2013-10-21 |
2022-09-15 |
옵코 바이오로직스 리미티드 |
Long-acting polypeptides and methods of producing and administering same
|
US20150158926A1
(en)
|
2013-10-21 |
2015-06-11 |
Opko Biologics, Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US10767156B2
(en)
|
2013-10-24 |
2020-09-08 |
Yeda Research And Development Co., Ltd. |
Polynucleotides encoding BREX system polypeptides and methods of using same
|
CA2928315C
(en)
|
2013-10-31 |
2023-03-21 |
Biokine Therapeutics Ltd. |
Methods of treating acute myeloid leukemia with a flt3 mutation
|
AU2014341879B2
(en)
|
2013-11-04 |
2020-07-23 |
Beeologics, Inc. |
Compositions and methods for controlling arthropod parasite and pest infestations
|
CA2925698C
(en)
|
2013-11-28 |
2021-11-09 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Rna polymerase i inhibitors and uses thereof
|
EP3074044A2
(en)
|
2013-11-28 |
2016-10-05 |
Yeda Research and Development Co., Ltd. |
Synaptojanin-2 inhibitors and uses thereof
|
DK3080243T3
(en)
|
2013-12-10 |
2019-01-07 |
Yeda Res & Dev |
USE OF ENZYMES THAT CATALYZE PYRUVATH SYNTHESIS FROM FORMIATE AND ACETYL COA, AND BACTERIES THAT EXPRESS THIS
|
UA119253C2
(en)
|
2013-12-10 |
2019-05-27 |
Біолоджикс, Інк. |
Compositions and methods for virus control in varroa mite and bees
|
AR099092A1
(en)
|
2014-01-15 |
2016-06-29 |
Monsanto Technology Llc |
METHODS AND COMPOSITIONS FOR WEED CONTROL USING EPSPS POLYUCLEOTIDES
|
US20160340659A1
(en)
|
2014-01-30 |
2016-11-24 |
Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. |
Actin binding peptides and compositions comprising same for inhibiting angiogenesis and treating medical conditions associated with same
|
JP2017506259A
(en)
|
2014-02-03 |
2017-03-02 |
イッスム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム・リミテッドYissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Use of casein kinase I inhibitors to deplete stem cells
|
US10125365B2
(en)
|
2014-02-05 |
2018-11-13 |
Yeda Research And Development Co. Ltd. |
Micro-RNAs and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions
|
WO2015118538A1
(en)
|
2014-02-06 |
2015-08-13 |
Yeda Research And Development Co. Ltd. |
Anti cd84 antibodies, compositions comprising same and uses thereof
|
WO2015118547A1
(en)
|
2014-02-10 |
2015-08-13 |
Protalix Ltd. |
Method of maintaining disease stability in a subject having gaucher's disease
|
EP3105587B1
(en)
|
2014-02-11 |
2023-09-06 |
Brainstorm Cell Therapeutics Ltd. |
Method of qualifying cells
|
US20170067894A1
(en)
|
2014-03-03 |
2017-03-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method and device for detection of pseudomonas aeruginosa
|
EP2923709A1
(en)
|
2014-03-28 |
2015-09-30 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Multi-component-multistage malaria vaccine
|
CN106413390B
(en)
|
2014-04-01 |
2019-09-27 |
孟山都技术公司 |
For controlling the composition and method of insect pest
|
US11433163B2
(en)
|
2014-04-10 |
2022-09-06 |
Bonus Therapeutics Ltd. |
Bone repair compositions
|
CN106574296B
(en)
|
2014-04-14 |
2021-03-02 |
耶路撒冷希伯来大学伊森姆研究发展公司 |
Method and kit for determining tissue or cell origin of DNA
|
ES2764504T3
(en)
|
2014-04-17 |
2020-06-03 |
Yeda Res & Dev |
Methods and equipment to analyze DNA-binding residues attached to DNA
|
US11427647B2
(en)
|
2014-04-27 |
2022-08-30 |
Famewave Ltd. |
Polynucleotides encoding humanized antibodies against CEACAM1
|
AP2016009564A0
(en)
|
2014-04-27 |
2016-11-30 |
Ccam Biotherapeutics Ltd |
Humanized antibodies against ceacam1
|
WO2015166492A2
(en)
|
2014-04-28 |
2015-11-05 |
Yeda Research And Development Co. Ltd. |
Microbiome response to agents
|
SG11201609039QA
(en)
|
2014-05-04 |
2016-11-29 |
Forrest Innovations Ltd |
Compositions for mosquito control and uses of same
|
US10294482B2
(en)
|
2014-05-22 |
2019-05-21 |
Yeda Research And Development Co. Ltd. |
Recombinant microorganisms capable of carbon fixation
|
WO2015186129A1
(en)
|
2014-06-02 |
2015-12-10 |
Technion Research & Development Foundation Limited. |
Compositions and methods of selectively inhibiting irp1 and treating inflammation
|
WO2015186128A1
(en)
|
2014-06-02 |
2015-12-10 |
Kadimastem Ltd. |
Methods of inducing myelination and maturation of oligodendrocytes
|
US10988764B2
(en)
|
2014-06-23 |
2021-04-27 |
Monsanto Technology Llc |
Compositions and methods for regulating gene expression via RNA interference
|
WO2015198320A1
(en)
|
2014-06-24 |
2015-12-30 |
Insight Biopharmaceuticals Ltd. |
Methods of purifying antibodies
|
CN106537148B
(en)
|
2014-06-25 |
2019-10-11 |
泰尔哈绍梅尔医学研究基础设施和服务有限公司 |
Cancer stem cell identification and its for diagnosing and treating purposes
|
US11807857B2
(en)
|
2014-06-25 |
2023-11-07 |
Monsanto Technology Llc |
Methods and compositions for delivering nucleic acids to plant cells and regulating gene expression
|
WO2015198326A1
(en)
|
2014-06-26 |
2015-12-30 |
Ramot At Tel-Aviv University Ltd. |
Liposomal formulations for delivery of nucleic acids
|
WO2016005985A2
(en)
|
2014-07-09 |
2016-01-14 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method for reprogramming cells
|
RU2017104284A
(en)
|
2014-07-15 |
2018-08-15 |
Йиссум Рисеч Девелопмент Компани Оф Зе Хебрю Юниверсити Оф Джерусалем Лтд. |
ISOLATED POLYPEPTIDES CD44 AND THEIR APPLICATION
|
JP6837428B2
(en)
|
2014-07-21 |
2021-03-10 |
ノベルラスディクス リミテッド |
Methods and systems for determining the carcinogenicity index of patient-specific mutations
|
WO2016013007A1
(en)
|
2014-07-21 |
2016-01-28 |
Novellusdx Ltd. |
Methods for determining drug response of patient specific mutations
|
RU2754955C2
(en)
|
2014-07-29 |
2021-09-08 |
Монсанто Текнолоджи Ллс |
Compositions and methods for combating insect pests
|
CN108064274A
(en)
|
2014-07-30 |
2018-05-22 |
耶达研究及发展有限公司 |
For cultivating the culture medium of multipotential stem cell
|
US10303846B2
(en)
|
2014-08-14 |
2019-05-28 |
Memed Diagnostics Ltd. |
Computational analysis of biological data using manifold and a hyperplane
|
WO2016030899A1
(en)
|
2014-08-28 |
2016-03-03 |
Yeda Research And Development Co. Ltd. |
Methods of treating amyotrophic lateral scleroses
|
EP2992895A1
(en)
|
2014-09-08 |
2016-03-09 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Three-component-multistage malaria vaccine
|
US10526416B2
(en)
|
2014-09-08 |
2020-01-07 |
Yeda Research And Development Co. Ltd. |
Anti-HER3 antibodies and uses of same
|
WO2016038610A1
(en)
|
2014-09-08 |
2016-03-17 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for treating cancer resistant to a tyrosine kinase inhibitor (tki)
|
IL234638A0
(en)
|
2014-09-14 |
2014-12-02 |
Yeda Res & Dev |
Nmda receptor antagonists for treating gaucher disease
|
CN106999608A
(en)
|
2014-09-21 |
2017-08-01 |
耶路撒冷希伯来大学伊森姆研究发展公司 |
MIR 132 is lowered to treat lipid-associated disorders
|
DE102015220401B4
(en)
|
2014-10-20 |
2022-12-29 |
Gen-Probe Incorporated |
Erythrocyte Lysis Solution
|
CN107406825B
(en)
|
2014-11-13 |
2022-04-08 |
恩祖迪克控股有限公司 |
Functional sex reversal in females of the decapod crustacean order
|
CN107429291A
(en)
|
2014-11-17 |
2017-12-01 |
耶达研究及发展有限公司 |
The method for analyzing microorganism group
|
WO2016079736A2
(en)
|
2014-11-17 |
2016-05-26 |
Yeda Research And Development Co. Ltd. |
Methods of treating diseases related to mitochondrial function
|
CN107810271B
(en)
|
2014-11-20 |
2021-09-28 |
耶路撒冷希伯来大学伊萨姆研发公司 |
Compositions and methods for producing polypeptides with altered glycosylation patterns in plant cells
|
EP3224353B9
(en)
|
2014-11-26 |
2023-08-09 |
Technology Innovation Momentum Fund (Israel) Limited Partnership |
Targeted elimination of bacterial genes
|
WO2016084084A1
(en)
|
2014-11-27 |
2016-06-02 |
Danziger Innovations Ltd. |
Nucleic acid constructs for genome editing
|
US10688330B2
(en)
|
2014-12-11 |
2020-06-23 |
Yeda Research And Development Co. Ltd. |
Isolated phosphotriesterase polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
WO2016103269A1
(en)
|
2014-12-23 |
2016-06-30 |
Ramot At Tel-Aviv University Ltd. |
Populations of neural progenitor cells and methods of producing and using same
|
IL273405B2
(en)
|
2014-12-30 |
2024-01-01 |
Cell Cure Neurosciences Ltd |
Rpe cell populations and methods of generating same
|
CA3175175A1
(en)
|
2014-12-30 |
2016-07-07 |
Cell Cure Neurosciences Ltd. |
Methods of treating retinal diseases
|
ES2880346T3
(en)
|
2014-12-30 |
2021-11-24 |
Cell Cure Neurosciences Ltd |
Evaluation of retinal pigment epithelial cell populations
|
RU2017125957A
(en)
|
2015-01-04 |
2019-02-04 |
Проталикс Лтд. |
MODIFIED DNA AND ITS APPLICATIONS
|
WO2016116935A1
(en)
|
2015-01-21 |
2016-07-28 |
Yeda Research And Development Co. Ltd. |
Use of rasa2 as a prognostic and therapeutic marker for melanoma
|
EP3256589B1
(en)
|
2015-01-22 |
2021-12-22 |
Monsanto Technology LLC |
Compositions and methods for controlling leptinotarsa
|
WO2016135732A1
(en)
|
2015-02-26 |
2016-09-01 |
Yeda Research And Development Co. Ltd. |
Method of promoting hair growth
|
EP3268475B1
(en)
|
2015-03-11 |
2020-10-21 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Decoy oligonucleotides for the treatment of diseases
|
IL237852A0
(en)
|
2015-03-19 |
2016-03-24 |
Yeda Res & Dev |
Anti amphiregulin antibodies, compositions comprising same and uses thereof
|
EP3273994B1
(en)
|
2015-03-27 |
2021-12-01 |
University of Southern California |
Car t-cell therapy directed to lhr for the treatment of solid tumors
|
EP3273971A4
(en)
|
2015-03-27 |
2018-12-05 |
Yeda Research and Development Co. Ltd. |
Methods of treating motor neuron diseases
|
RU2017135552A
(en)
|
2015-03-31 |
2019-04-30 |
Иеда Рисеч Энд Девелопмент Ко. Лтд. |
GLUTAMATE TRANSMINASE OXALOACETATE 1 (GOT1), PREPARATIONS AND METHODS FOR THEIR RECEPTION AND APPLICATION
|
WO2016157192A1
(en)
|
2015-04-01 |
2016-10-06 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Erodium crassifolium l'her plant extracts and uses thereof
|
CA2981732C
(en)
|
2015-04-07 |
2024-03-12 |
Boris Khalfin |
Compositions for treating and/or preventing cell or tissue necrosis specifically targeting cathepsin c and/or cela1 and/or cela3a and/or structurally related enzymes thereto
|
EP3081575A1
(en)
|
2015-04-12 |
2016-10-19 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Anti-plasmodium parasite antibodies
|
CN108135863B
(en)
|
2015-04-27 |
2021-07-27 |
特拉维夫医疗中心医学研究基础设施和保健服务基金会 |
EGR1 targeting molecules for the treatment of inflammatory and hyperproliferative conditions
|
US10674732B2
(en)
|
2015-04-29 |
2020-06-09 |
The State Of Israel, Ministry Of Agriculture & Rural Development Agricultural Research Organization |
Anti-phytopathogenic compositions
|
US20190031759A1
(en)
|
2015-04-30 |
2019-01-31 |
Technion Research & Development Foundation Limited |
Chimeric antigen receptors and methods of their use
|
EP3292219B9
(en)
|
2015-05-04 |
2022-05-18 |
Ramot at Tel-Aviv University Ltd. |
Methods and kits for fragmenting dna
|
EP3294280A1
(en)
|
2015-05-11 |
2018-03-21 |
Yeda Research and Development Co., Ltd. |
Citrin inhibitors for the treatment of cancer
|
US11219636B2
(en)
|
2015-05-17 |
2022-01-11 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Compositions and methods for treating cancer
|
WO2016185457A1
(en)
|
2015-05-19 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Methods of promoting lymphangiogenesis
|
EP3297680A2
(en)
|
2015-05-20 |
2018-03-28 |
Yeda Research and Development Co. Ltd |
Method of targeting senescent cells
|
EA201792547A1
(en)
|
2015-05-21 |
2018-04-30 |
Иеда Рисеч Энд Девелопмент Ко. Лтд. |
BACTERIA POPULATIONS FOR STIMULATING HEALTH CONDITION
|
MX2017015375A
(en)
|
2015-05-29 |
2018-06-19 |
Opko Biologics Ltd |
Pegylated oxyntomodulin variants.
|
UY36703A
(en)
|
2015-06-02 |
2016-12-30 |
Monsanto Technology Llc |
COMPOSITIONS AND METHODS FOR THE ADMINISTRATION OF A POLINUCLEOTIDE ON A PLANT
|
WO2016196782A1
(en)
|
2015-06-03 |
2016-12-08 |
Monsanto Technology Llc |
Methods and compositions for introducing nucleic acids into plants
|
US10711064B2
(en)
|
2015-06-04 |
2020-07-14 |
University Of Southern California |
Lym-1 and Lym-2 targeted CAR cell immunotherapy
|
NL2014935B1
(en)
|
2015-06-08 |
2017-02-03 |
Applied Immune Tech Ltd |
T cell receptor like antibodies having fine specificity.
|
WO2016203476A1
(en)
|
2015-06-18 |
2016-12-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods and compositions for diagnosing and treating urothelial cancer
|
ES2917884T3
(en)
|
2015-06-18 |
2022-07-12 |
Yeda Res & Dev |
Conditioning protocols and their use for tissue regeneration
|
WO2016203482A2
(en)
|
2015-06-19 |
2016-12-22 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
CN116196426A
(en)
|
2015-07-16 |
2023-06-02 |
百欧肯治疗有限公司 |
Compositions and methods for treating cancer
|
ES2963038T3
(en)
|
2015-07-16 |
2024-03-25 |
Yeda Res & Dev |
Use of anti-third central memory T cells
|
US10668094B2
(en)
|
2015-07-19 |
2020-06-02 |
Yeda Research And Development Co. Ltd. |
Selective inhibitors of Alpha2-containing isoforms of Na,K-ATPase and use thereof for reduction of intraocular pressure
|
CA2993023C
(en)
|
2015-07-22 |
2020-04-28 |
Phytopharma International Ltd. |
Bee-ingestible compositions, methods of using same for producing honey and honey produced thereby
|
WO2017017686A1
(en)
|
2015-07-29 |
2017-02-02 |
Hadasit Medical Research Services And Development Ltd. |
Large scale production of retinal pigment epithelial cells
|
EP3331546B1
(en)
|
2015-08-03 |
2023-10-04 |
Biokine Therapeutics Ltd. |
Cxcr4 inhibitor for the treatment of cancer
|
WO2017021961A1
(en)
|
2015-08-04 |
2017-02-09 |
Yeda Research And Development Co. Ltd. |
Methods of screening for riboswitches and attenuators
|
EA201890424A1
(en)
|
2015-08-05 |
2018-06-29 |
Селл Кьюр Нейросайансес Лтд. |
OBTAINING CELL PIGMENT EPITHELIUM CELLS
|
US11090337B2
(en)
|
2015-08-05 |
2021-08-17 |
Cell Cure Neurosciences Ltd |
Preparation of photoreceptors for the treatment of retinal diseases
|
WO2017025963A1
(en)
|
2015-08-10 |
2017-02-16 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Methods and pharmaceutical compositions for improving wound healing using cd24
|
WO2017025967A1
(en)
|
2015-08-13 |
2017-02-16 |
Forrest Innovations Ltd. |
Formulations and compositions for delivery of nucleic acids to plant cells
|
WO2017033188A1
(en)
|
2015-08-24 |
2017-03-02 |
Yeda Research And Development Co. Ltd. |
Algal oil and biofuel and methods of producing same
|
US10765706B2
(en)
|
2015-09-03 |
2020-09-08 |
University Of South Florida |
Method of stem cell delivery into the brain during chronic disease using blood brain barrier permeabilizers
|
WO2017042816A1
(en)
|
2015-09-10 |
2017-03-16 |
Yeda Research And Development Co. Ltd. |
Ablation of perforin positive dendritic cells in cancer treatment
|
WO2017072757A1
(en)
|
2015-10-25 |
2017-05-04 |
Yeda Research And Development Co. Ltd. |
Antibodies targeting quiescin sulfhydryl oxidase (qsox1) and uses of same
|
WO2017072763A1
(en)
|
2015-10-26 |
2017-05-04 |
Cell Cure Neurosciences Ltd. |
Preparation of retinal pigment epithelium cells
|
KR20180102053A
(en)
|
2015-10-27 |
2018-09-14 |
제이 파마 인코포레이티드 |
A composition for treating cancer, comprising cannabidiol and a second therapeutic agent
|
IL242380A0
(en)
|
2015-10-29 |
2016-02-01 |
Yeda Res & Dev |
A method of inducing cardiomyocytes proliferation and treating heart diseases
|
WO2017077539A1
(en)
|
2015-11-03 |
2017-05-11 |
Ariel-University Research And Development Company Ltd. |
Compositions for regeneration and repair of neural tissue
|
US20180327855A1
(en)
|
2015-11-11 |
2018-11-15 |
Ramot At Tel-Aviv University Ltd. |
Methods of detecting 5-hydroxymethylcytosine and diagnosing of cancer
|
US11679133B2
(en)
|
2015-11-30 |
2023-06-20 |
Kadimastem Ltd. |
Methods for differentiating and purifying pancreatic endocrine cells
|
EP3176183A1
(en)
|
2015-12-02 |
2017-06-07 |
Yeda Research and Development Co. Ltd |
Compositions and methods for treating cancer not resistant to a tyrosine kinase inhibitor (tki)
|
EP4059507B1
(en)
|
2015-12-16 |
2024-06-05 |
Ramot at Tel-Aviv University Ltd. |
Particles comprising decellularized omentum
|
IL260331B1
(en)
|
2015-12-28 |
2024-06-01 |
B G Negev Technologies And Applications Ltd At Ben Gurion Univ |
Composition and method for treating amyotrophic lateral sclerosis
|
US10828318B2
(en)
|
2016-01-06 |
2020-11-10 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for treating malignant, autoimmune and inflammatory diseases
|
US20190178888A1
(en)
|
2016-01-11 |
2019-06-13 |
Technion Research & Development Foundation Limited |
Methods of determining prognosis of sepsis and treating same
|
CN109068605B
(en)
|
2016-01-21 |
2022-11-11 |
以色列国家农业和农村发展农业研究组织沃尔坎尼中心 |
Parthenocarpic plants and methods of producing the same
|
IL243839B
(en)
|
2016-01-28 |
2018-01-31 |
Sp Nano Ltd |
Conductive yarn
|
IL243838A
(en)
|
2016-01-28 |
2017-07-31 |
Sp Nano Ltd |
Composition comprising sp1 and carbon based nanoparticles and uses thereof
|
WO2017130205A1
(en)
|
2016-01-31 |
2017-08-03 |
Hadasit Medical Research Services And Development Ltd. |
Autosomal-identical pluripotent stem cell populations having non-identical sex chromosomal composition and uses thereof
|
RU2762089C2
(en)
|
2016-02-04 |
2021-12-15 |
Иеда Рисеч Энд Девелопмент Ко. Лтд. |
PEPTIDES AND THEIR USE IN TREATMENT OF DISEASES, DISORDERS OR CONDITIONS ASSOCIATED WITH MUTANT p53
|
WO2017138008A2
(en)
|
2016-02-14 |
2017-08-17 |
Yeda Research And Development Co. Ltd. |
Methods of modulating protein exocytosis and uses of same in therapy
|
WO2017138007A1
(en)
|
2016-02-14 |
2017-08-17 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Microbiome-based diagnosis, prediction and treatment of relapsing obesity
|
CA3014889A1
(en)
|
2016-02-16 |
2017-08-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Non-protein phenylalanine analogues for inhibiting cyanobacteria and plant growth
|
WO2017145162A1
(en)
|
2016-02-23 |
2017-08-31 |
Chaya Brodie |
Generation of cancer stem cells and use thereof
|
MX2018010445A
(en)
|
2016-03-01 |
2019-10-17 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Antibodies specific to human poliovirus receptor (pvr).
|
WO2017149547A1
(en)
|
2016-03-03 |
2017-09-08 |
Memed Diagnostics Ltd. |
Analyzing rna for diagnosing infection type
|
US20190216891A1
(en)
|
2016-03-06 |
2019-07-18 |
Yeda Research And Development Co., Ltd. |
Method for modulating myelination
|
IL244649A0
(en)
|
2016-03-17 |
2016-06-30 |
Yeda Res & Dev |
Methods of isolating barrel-like proteases and identifying peptides processed thereby
|
US10421785B2
(en)
|
2016-04-11 |
2019-09-24 |
Bar-Ilan University |
Delta receptor agonist peptides and use thereof
|
CA3021914C
(en)
|
2016-04-27 |
2024-04-30 |
Gen-Probe Incorporated |
Blood cell lysis reagent
|
EP3463402B1
(en)
|
2016-05-22 |
2021-06-23 |
Yeda Research and Development Co. Ltd. |
Methods of using pulmonary cells for transplantation and induction of tolerance
|
IL245861A0
(en)
|
2016-05-25 |
2016-09-04 |
Yeda Res & Dev |
Use of agents for treating drug resistant tumors
|
US20190100732A1
(en)
|
2016-06-02 |
2019-04-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Assay for the removal of methyl-cytosine residues from dna
|
US11820833B2
(en)
|
2016-06-05 |
2023-11-21 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Peptides that inhibit binding of EPCR to its ligand to treat inflammation
|
US20190160152A1
(en)
|
2016-06-09 |
2019-05-30 |
Opko Biologics Ltd. |
Long-acting oxyntomodulin formulation and methods of producing and administering same
|
EP3472342A1
(en)
|
2016-06-19 |
2019-04-24 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Screening for chemotherapy resistance in human haploid cells
|
CA3029001A1
(en)
|
2016-06-27 |
2018-01-04 |
Yeda Research And Development Co. Ltd. |
Veto cells generated from memory t cells
|
EP3482200B1
(en)
|
2016-07-10 |
2022-05-04 |
Memed Diagnostics Ltd. |
Protein signatures for distinguishing between bacterial and viral infections
|
EP4184167A1
(en)
|
2016-07-10 |
2023-05-24 |
MeMed Diagnostics Ltd. |
Early diagnosis of infections
|
WO2018011805A2
(en)
|
2016-07-11 |
2018-01-18 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Systems and methods for growing cells in vitro
|
IL246722A0
(en)
|
2016-07-11 |
2016-09-29 |
Yeda Res & Dev |
Combination therapy to increase endogenous nitric oxide (no) synthesis
|
BR112019000610A2
(en)
|
2016-07-11 |
2019-07-02 |
Opko Biologics Ltd |
long-acting coagulation factor vii and production methods thereof
|
WO2018011804A1
(en)
|
2016-07-11 |
2018-01-18 |
Bonus Therapeutics Ltd. |
Cell compositions for tissue regeneration
|
WO2018015881A1
(en)
|
2016-07-18 |
2018-01-25 |
Ramot At Tel-Aviv University Ltd. |
Modular platform for targeted therapeutics
|
US20190203270A1
(en)
|
2016-07-24 |
2019-07-04 |
Yeda Research And Development Co., Ltd. |
Methods and kits for analyzing dna binding moieties attached to dna
|
WO2018029682A1
(en)
|
2016-08-08 |
2018-02-15 |
Ramot At Tel-Aviv University Ltd. |
Bacterial systems for analyzing ubiquitylated polypeptides
|
CN109844532B
(en)
|
2016-08-10 |
2022-06-17 |
米密德诊断学有限公司 |
System and method for analyzing biological data
|
EP3497239A4
(en)
|
2016-08-10 |
2020-02-26 |
Ramot at Tel-Aviv University Ltd. |
Analysis of methylation status and copy number
|
JP7014449B2
(en)
|
2016-08-14 |
2022-02-01 |
ラモット アット テル アビブ ユニバーシティ, リミテッド |
Mesenchymal cell-derived exosomes for treating neuropathy
|
IL247368A0
(en)
|
2016-08-18 |
2016-11-30 |
Yeda Res & Dev |
Diagnostic and therapeutic uses of exosomes
|
WO2018037416A1
(en)
|
2016-08-25 |
2018-03-01 |
Yeda Research And Development Co. Ltd. |
Methods and compositions for treating autoimmune diseases
|
JP2020501506A
(en)
|
2016-09-07 |
2020-01-23 |
イッサム リサーチ デベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム エルティーディー. |
Anti-NKp46 antibody and therapeutic use thereof
|
US11485971B2
(en)
|
2016-09-14 |
2022-11-01 |
Yeda Research And Development Co. Ltd. |
CRISP-seq, an integrated method for massively parallel single cell RNA-seq and CRISPR pooled screens
|
EP3519833A4
(en)
|
2016-09-29 |
2020-06-03 |
MeMed Diagnostics Ltd. |
Methods of prognosis and treatment
|
IL248468A0
(en)
|
2016-10-13 |
2017-01-31 |
Technion Res & Dev Foundation |
Use of caspase-3 inhibitors and caspase-3 activators in the manufacture of medicament for treating cancer and wound healing
|
IL248385A0
(en)
|
2016-10-18 |
2017-02-01 |
Yeda Res & Dev |
Treatment of a circadian rhythm disorder
|
US20190359956A1
(en)
|
2016-11-10 |
2019-11-28 |
Yeda Research And Development Co. Ltd. |
Phosphotriesterases for treating or preventing organophosphate exposure associated damage
|
CN110234765A
(en)
|
2016-11-28 |
2019-09-13 |
耶达研究及发展有限公司 |
Isolated polynucleotides and polypeptides and make the method for being used to express interested expression product
|
EP3548015A1
(en)
|
2016-11-30 |
2019-10-09 |
Yeda Research and Development Co. Ltd. |
Methods of treating liver toxicity and disorders
|
SG11201810936VA
(en)
|
2016-12-01 |
2019-01-30 |
Univ Ramot |
Combined treatment for nerve injuries
|
CN110392736A
(en)
|
2017-01-18 |
2019-10-29 |
耶达研究及发展有限公司 |
The veto cell of genetic modification and its purposes in immunization therapy
|
IL250479A0
(en)
|
2017-02-06 |
2017-03-30 |
Sorek Rotem |
Isolated cells genetically modified to express a disarm system having an anti-phage activity and methods of producing same
|
IL250916A0
(en)
|
2017-03-02 |
2017-06-29 |
Geiger Benjamin |
Methods of culturing t cells and uses of same
|
EP3596469A1
(en)
|
2017-03-12 |
2020-01-22 |
Yeda Research and Development Co., Ltd. |
Methods of diagnosing and prognosing cancer
|
WO2018167780A1
(en)
|
2017-03-12 |
2018-09-20 |
Yeda Research And Development Co. Ltd. |
Methods of prognosing and treating cancer
|
CN118021843A
(en)
|
2017-03-16 |
2024-05-14 |
谱系细胞疗法公司 |
Method for measuring efficacy of retinal disease therapy
|
US11920162B2
(en)
|
2017-04-05 |
2024-03-05 |
Yeda Research And Development Co. Ltd. |
Ex-vivo culture system and methods of using same
|
IL252151A0
(en)
|
2017-05-07 |
2017-07-31 |
Fainzilber Michael |
Methods of treating psychiatric stress disorders
|
KR20200004880A
(en)
|
2017-05-10 |
2020-01-14 |
아리엘 싸이언티픽 이노베이션스 엘티디. |
How to Purify Antibodies
|
ES2939298T3
(en)
|
2017-05-21 |
2023-04-20 |
Medical Res Infrastructure & Health Services Fund Tel Aviv Medical Ct |
Combination of markers for cancer diagnosis
|
EP3634991A1
(en)
|
2017-05-23 |
2020-04-15 |
Technion Research & Development Foundation Limited |
Agents which inhibit gads dimerization and methods of use thereof
|
WO2018220582A1
(en)
|
2017-05-31 |
2018-12-06 |
Tropic Biosciences UK Limited |
Methods of selecting cells comprising genome editing events
|
GB201708665D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing extractability of solids from coffee beans
|
GB201708662D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing shelf-life of banana
|
WO2018229764A1
(en)
|
2017-06-13 |
2018-12-20 |
Yeda Research And Development Co. Ltd. |
Treatment of advanced or progressive multiple sclerosis
|
US11466323B2
(en)
|
2017-07-13 |
2022-10-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Dual-probe digital droplet PCR strategy for specific detection of tissue-specific circulating DNA molecules
|
WO2019012542A1
(en)
|
2017-07-13 |
2019-01-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Detecting tissue-specific dna
|
US20200340057A1
(en)
|
2017-07-13 |
2020-10-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Dna targets as tissue-specific methylation markers
|
IL253642A0
(en)
|
2017-07-24 |
2017-09-28 |
Seger Rony |
Combination therapy for the treatment of cancer
|
IL253984A0
(en)
|
2017-08-14 |
2017-09-28 |
Yeda Res & Dev |
Immunotherapy against transferrin receptor 1 (tfr1)-tropic arenaviruses
|
US11692166B2
(en)
|
2017-08-23 |
2023-07-04 |
Technion Research & Development Foundation Limited |
Compositions and methods for improving alcohol tolerance in yeast
|
US11555199B2
(en)
|
2017-09-19 |
2023-01-17 |
Tropic Biosciences UK Limited |
Modifying the specificity of plant non-coding RNA molecules for silencing gene expression
|
US11591385B2
(en)
|
2017-11-09 |
2023-02-28 |
Pinteon Therapeutics Inc. |
Methods and compositions for the generation and use of humanized conformation-specific phosphorylated tau antibodies
|
IL255664A0
(en)
|
2017-11-14 |
2017-12-31 |
Shachar Idit |
Hematopoietic stem cells with improved properties
|
US20200390800A1
(en)
|
2017-11-29 |
2020-12-17 |
Ramot At Tel-Aviv University Ltd. |
Methods of preventing or treating neurogenic shock
|
BR112020010830A2
(en)
|
2017-11-29 |
2020-11-10 |
Weedout Ltd. |
compositions, kits and methods for controlling weed of the genus amaranthus
|
WO2019106680A1
(en)
|
2017-12-03 |
2019-06-06 |
Yeda Research And Development Co. Ltd. |
Treatment of an ischemic heart disease
|
WO2019116376A1
(en)
|
2017-12-17 |
2019-06-20 |
Yeda Research And Development Co. Ltd. |
Cop9 signalosome (csn) complex modulators and uses thereof
|
WO2019130313A1
(en)
|
2017-12-28 |
2019-07-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method to reproduce circadian rhythms on a microfluidic chip
|
IL257225A
(en)
|
2018-01-29 |
2018-04-09 |
Yeda Res & Dev |
Treatment of sarcoma
|
IL257269A
(en)
|
2018-01-31 |
2018-04-09 |
Olender Tsviya |
Endoplasmic reticulum targeting signal
|
EP3749368A1
(en)
|
2018-02-08 |
2020-12-16 |
Yeda Research and Development Co. Ltd |
Methods of identifying and using agents for treating diseases associated with intestinal barrier dysfunction
|
EP3749689A1
(en)
|
2018-02-08 |
2020-12-16 |
Yeda Research and Development Co. Ltd |
Inhibitors of the 20s proteasome
|
WO2019162945A1
(en)
|
2018-02-23 |
2019-08-29 |
Carmel Haifa University Economic Corporation Ltd. |
Methods for treating memory impairment and cognitive dysfunction
|
EP3759493A1
(en)
|
2018-02-28 |
2021-01-06 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Methods of diagnosing and treating bladder cancer
|
EP3765034A1
(en)
|
2018-03-12 |
2021-01-20 |
Yeda Research and Development Co. Ltd |
Treatment of a heart disease
|
IL258467A
(en)
|
2018-03-29 |
2018-07-04 |
Ilana Kolodkin Gal |
Methods of disrupting a biofilm and/or preventing formation of same
|
WO2019186569A1
(en)
|
2018-03-29 |
2019-10-03 |
Yeda Research And Development Co. Ltd. |
Use of electric field gradients to control gene expression
|
JP2021519283A
(en)
|
2018-03-29 |
2021-08-10 |
テクニオン・リサーチ・アンド・ディベロップメント・ファウンデーション・リミテッド |
Vesicles containing PTEN inhibitors and their use
|
GB201807192D0
(en)
|
2018-05-01 |
2018-06-13 |
Tropic Biosciences Uk Ltd |
Compositions and methods for reducing caffeine content in coffee beans
|
WO2019220441A1
(en)
|
2018-05-15 |
2019-11-21 |
Hadasit Medical Research Services And Development Ltd. |
Compositions and methods for treating cancer resistant to an anti-cancer agent
|
IL259392A
(en)
|
2018-05-15 |
2018-08-01 |
Yeda Res & Dev |
Vaccination with cancer neoantigens
|
CA3099383A1
(en)
|
2018-05-27 |
2019-12-05 |
Biolinerx Ltd. |
Agi-134 combined with a checkpoint inhibitor for the treatment of solid tumors
|
CA3102975A1
(en)
|
2018-06-07 |
2019-12-12 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Methods of regenerating and transforming cannabis
|
WO2019234754A1
(en)
|
2018-06-07 |
2019-12-12 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Nucleic acid constructs and methods of using same
|
US11873322B2
(en)
|
2018-06-25 |
2024-01-16 |
Yeda Research And Development Co. Ltd. |
Systems and methods for increasing efficiency of genome editing
|
AU2019297677A1
(en)
|
2018-07-04 |
2021-02-25 |
Ukko Inc. |
Methods of de-epitoping wheat proteins and use of same for the treatment of celiac disease
|
WO2020012467A2
(en)
|
2018-07-08 |
2020-01-16 |
Yeda Research And Development Co. Ltd. |
Person-specific assessment of probiotics responsiveness
|
JP7395517B2
(en)
|
2018-07-11 |
2023-12-11 |
イミュニティ ファルマ リミテッド |
Peptide compounds and their therapeutic uses
|
US20210214417A1
(en)
|
2018-07-11 |
2021-07-15 |
Kahr Medical Ltd. |
SIRPalpha-4-1BBL VARIANT FUSION PROTEIN AND METHODS OF USE THEREOF
|
EP3827087A1
(en)
|
2018-07-31 |
2021-06-02 |
CollPlant Ltd. |
Tobacco transgenic event and methods for detection and use thereof
|
IL261156A
(en)
|
2018-08-14 |
2020-02-27 |
Fass Deborah |
Chimeric quiescin sulfhydryl oxidase (qsox1) antibodies and uses of same
|
WO2020039440A1
(en)
|
2018-08-24 |
2020-02-27 |
Yeda Research And Development Co. Ltd. |
Methods of modulating m2 macrophage polarization and use of same in therapy
|
US20210353611A1
(en)
|
2018-09-20 |
2021-11-18 |
Yeda Research And Development Co. Ltd. |
Methods of treating amyotrophic lateral sclerosis
|
EP3856225A1
(en)
|
2018-09-25 |
2021-08-04 |
BioLineRx Ltd. |
Methods of selecting treatment for cxcr4-associated cancer
|
IL262658A
(en)
|
2018-10-28 |
2020-04-30 |
Memorial Sloan Kettering Cancer Center |
Prevention of age related clonal hematopoiesis and diseases associated therewith
|
IL263184A
(en)
|
2018-11-21 |
2020-05-31 |
Yarden Yosef |
Method of treating cancer and compositions for same
|
EP3914698A1
(en)
|
2019-01-23 |
2021-12-01 |
Yeda Research and Development Co. Ltd |
Culture media for pluripotent stem cells
|
IL264768A
(en)
|
2019-02-10 |
2020-08-31 |
Sagi Irit |
Anti-matrix metalloproteinase 7 (mmp-7) inhibitory antibody and uses thereof
|
IL264854A
(en)
|
2019-02-14 |
2020-08-31 |
Bahat Anat |
Spt5 inhibitors and methods of use thereof
|
EP3927807A1
(en)
|
2019-02-21 |
2021-12-29 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Methods of generating organoids for high throughput screening of drugs
|
JP2022521010A
(en)
|
2019-02-21 |
2022-04-04 |
イッスム・リサーチ・デベロプメント・カムパニー・オブ・ザ・ヘブリュー・ユニバシティー・オブ・エルサレム リミテッド |
Methods for reducing drug-induced nephrotoxicity
|
IL286011B2
(en)
|
2019-03-05 |
2024-06-01 |
The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization Aro Vo |
Genome-edited birds
|
GB201903521D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
No title
|
GB201903519D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Introducing silencing activity to dysfunctional rna molecules and modifying their specificity against a gene of interest
|
GB201903520D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Modifying the specificity of non-coding rna molecules for silencing genes in eukaryotic cells
|
IL265486A
(en)
|
2019-03-19 |
2020-09-30 |
Yeda Res & Dev |
Bistable type ii opsins and uses thereof
|
WO2020194317A1
(en)
|
2019-03-28 |
2020-10-01 |
Yeda Research And Development Co. Ltd. |
Method of treating lipid-related disorders
|
WO2020202142A2
(en)
|
2019-03-31 |
2020-10-08 |
Yeda Research And Development Co. Ltd. |
Anti-viral and anti-tumoral compounds
|
IL266433B
(en)
|
2019-05-02 |
2020-11-30 |
Sagi Irit |
Compositions comprising the propeptide of lysyl oxidase and uses thereof
|
WO2020230133A1
(en)
|
2019-05-13 |
2020-11-19 |
Yeda Research And Development Co. Ltd. |
Cell-free mirna biomarkers for prognosis and diagnosis of neurodegenerative diseases
|
IL266728B
(en)
|
2019-05-19 |
2020-11-30 |
Yeda Res & Dev |
Identification of recurrent mutated neopeptides
|
AU2020279080A1
(en)
|
2019-05-22 |
2022-01-20 |
Hadasit Medical Research Services And Development Ltd. |
Methods of culturing human pluripotent cells
|
GB2598520A
(en)
|
2019-05-28 |
2022-03-02 |
Univ Shanghai Technology |
Composition and methods to treat ectodermal dysplasia 2, Clouston type
|
JP2022536326A
(en)
|
2019-06-12 |
2022-08-15 |
ハダシット メディカル リサーチ サービシーズ アンド ディベロップメント リミテッド |
Method for producing oligodendrocytes
|
EP3983540A1
(en)
|
2019-06-16 |
2022-04-20 |
Yeda Research and Development Co. Ltd |
Method for stabilizing intracellular rna
|
EP3990488A4
(en)
|
2019-06-27 |
2023-09-13 |
Ramot at Tel-Aviv University Ltd. |
Semaphorin 3a antibodies and uses thereof
|
AU2020300101A1
(en)
|
2019-07-04 |
2022-02-17 |
Ukko Inc. |
De-epitoped alpha gliadin and use of same for the management of celiac disease and gluten sensitivity
|
EP3997114A1
(en)
|
2019-07-11 |
2022-05-18 |
KAHR Medical Ltd. |
Heterodimers and methods of use thereof
|
IL268111A
(en)
|
2019-07-16 |
2021-01-31 |
Fainzilber Michael |
Methods of treating pain
|
EP3999851A4
(en)
|
2019-07-16 |
2023-04-12 |
Ramot at Tel-Aviv University Ltd. |
Compositions and methods for the treatment of tuberculosis
|
WO2021019526A1
(en)
|
2019-07-29 |
2021-02-04 |
Yeda Research And Development Co. Ltd. |
Methods of treating and diagnosing lung cancer
|
US20220298522A1
(en)
|
2019-07-30 |
2022-09-22 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization |
Methods of controlling cannabinoid synthesis in plants or cells and plants and cells produced thereby
|
WO2021028909A1
(en)
|
2019-08-12 |
2021-02-18 |
Yeda Research And Development Co. Ltd. |
Dna repair blood test for predicting response of lung cancer patients to immunotherapy
|
US20240140988A1
(en)
|
2019-08-22 |
2024-05-02 |
Ariel Scientific Innovations Ltd. |
Scaled-up methods for purifying antibodies
|
EP4021463A1
(en)
|
2019-08-27 |
2022-07-06 |
Yeda Research and Development Co. Ltd |
Treatment of bacterial vaginosis
|
WO2021048852A1
(en)
|
2019-09-11 |
2021-03-18 |
Yeda Research And Development Co. Ltd. |
Methods of treating breast cancer
|
IL269674B
(en)
|
2019-09-25 |
2020-08-31 |
Roy Bar Ziv |
Assembly of protein complexes on a chip
|
IL270306A
(en)
|
2019-10-30 |
2021-05-31 |
Yeda Res & Dev |
Prevention and treatment of pre-myeloid and myeloid malignancies
|
WO2021084526A1
(en)
|
2019-10-31 |
2021-05-06 |
Yeda Research And Development Co. Ltd. |
Engineered autotrophic bacteria for co2 conversion to organic materials
|
JP2023501004A
(en)
|
2019-11-11 |
2023-01-17 |
アイビーアイ-エージー イノベイティブ バイオ インセクティサイズ リミテッド |
Insect control nanobodies and their uses
|
WO2021100034A1
(en)
|
2019-11-19 |
2021-05-27 |
Protalix Ltd. |
Removal of constructs from transformed cells
|
IL270800A
(en)
|
2019-11-20 |
2021-05-31 |
Yeda Res & Dev |
Method of treating alzheimer’s disease
|
WO2021130753A1
(en)
|
2019-12-22 |
2021-07-01 |
Yeda Research And Development Co. Ltd. |
Diagnosis of frontotemporal dementia
|
IL271656A
(en)
|
2019-12-22 |
2021-06-30 |
Yeda Res & Dev |
Systems and methods for identifying cells that have undergone genome editing
|
IL271778A
(en)
|
2019-12-31 |
2021-06-30 |
Ichilov Tech Ltd |
Methods of treating atopic dermatitis
|
US20230048719A1
(en)
|
2019-12-31 |
2023-02-16 |
Kahr Medical Ltd. |
Methods of culturing t cells with a 4-1bbl fusion polypeptide and uses of same
|
WO2021137230A1
(en)
|
2019-12-31 |
2021-07-08 |
Kahr Medical Ltd. |
Methods of culturing t cells and uses of same
|
IL272074A
(en)
|
2020-01-15 |
2021-07-29 |
Immunity Pharma Ltd |
Peptide compounds and methods of treating diseases using same
|
IL272194A
(en)
|
2020-01-22 |
2021-07-29 |
Yeda Res & Dev |
Multispecific antibodies for use in treating diseases
|
WO2021152584A1
(en)
|
2020-01-28 |
2021-08-05 |
Ariel Scientific Innovations Ltd. |
Methods of analyzing cell membranes
|
WO2021152587A1
(en)
|
2020-01-30 |
2021-08-05 |
Yeda Research And Development Co. Ltd. |
Treating acute liver disease with tlr-mik inhibitors
|
IL272390A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Methods of treating cancer
|
IL272389A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Articles of manufacture comprising anti pd-l1 antibodies and their use in therapy
|
WO2021152586A1
(en)
|
2020-01-30 |
2021-08-05 |
Yeda Research And Development Co. Ltd. |
Methods of analyzing microbiome, immunoglobulin profile and physiological state
|
WO2021156878A2
(en)
|
2020-02-09 |
2021-08-12 |
Nlc Pharma Ltd |
Rapid detection test for sars-cov-2
|
IL272586A
(en)
|
2020-02-10 |
2021-08-31 |
Yeda Res & Dev |
Method for analyzing cell clusters
|
EP4110823A1
(en)
|
2020-02-26 |
2023-01-04 |
A2 Biotherapeutics, Inc. |
Polypeptides targeting mage-a3 peptide-mhc complexes and methods of use thereof
|
EP4121441A1
(en)
|
2020-03-16 |
2023-01-25 |
Yeda Research and Development Co. Ltd |
Peptide analogs and use of same in treating diseases, disorders or conditions associated with a mutant p53 protein
|
CN115348884A
(en)
|
2020-03-29 |
2022-11-15 |
耶达研究及发展有限公司 |
Beta-glucocerebrosidase variants for the treatment of gaucher disease
|
CN115484836A
(en)
|
2020-03-31 |
2022-12-16 |
百欧穆斯有限公司 |
Bacteria for preventing and treating smoke-induced lung injury
|
EP4133107A1
(en)
|
2020-04-06 |
2023-02-15 |
Yeda Research and Development Co. Ltd |
Methods of diagnosing cancer and predicting responsiveness to therapy
|
EP4132479A1
(en)
|
2020-04-07 |
2023-02-15 |
Ramot at Tel-Aviv University Ltd. |
Cannabidiol-containing compositions and uses thereof
|
CA3177360A1
(en)
|
2020-04-13 |
2021-10-21 |
Exoprother Medical Ltd. |
Cell-derived vesicles comprising wild-type p53 protein for antiviral therapy
|
US20210322483A1
(en)
|
2020-04-16 |
2021-10-21 |
Ichilov Tech Ltd. |
Cell-derived particles presenting heterologous cd24 and use thereof in therapy
|
WO2021229577A1
(en)
|
2020-05-12 |
2021-11-18 |
Collplant Ltd. |
Collagen as a delivery tool for metal-based anti-viral agents
|
IL274811B
(en)
|
2020-05-20 |
2021-05-31 |
Yeda Res & Dev |
Indexing spatial information for a single-cell downstream applications
|
WO2021260675A1
(en)
|
2020-06-24 |
2021-12-30 |
Yeda Research And Development Co. Ltd. |
Agents for sensitizing solid tumors to treatment
|
IL276599A
(en)
|
2020-08-09 |
2022-03-01 |
Yeda Res & Dev |
Mage-a1 specific t cell receptor and uses thereof
|
IL276627A
(en)
|
2020-08-10 |
2022-03-01 |
Yeda Res & Dev |
Compositions for diagnosis and treatment of coronavirus infections
|
WO2022038536A1
(en)
|
2020-08-18 |
2022-02-24 |
International Rice Research Institute |
Methods of increasing outcrossing rates in gramineae
|
IL277488A
(en)
|
2020-09-21 |
2022-04-01 |
Yeda Res & Dev |
Method for modulating weight
|
WO2022064494A2
(en)
|
2020-09-23 |
2022-03-31 |
Yeda Research And Development Co. Ltd. |
Methods and compositions for treating coronaviral infections
|
IL277743A
(en)
|
2020-10-01 |
2022-04-01 |
Yeda Res & Dev |
Method of diagnosing breast cancer
|
US20230374447A1
(en)
|
2020-10-05 |
2023-11-23 |
Protalix Ltd. |
Dicer-like knock-out plant cells
|
IL301970A
(en)
|
2020-10-07 |
2023-06-01 |
Protalix Ltd |
Long-acting dnase
|
EP4228637A1
(en)
|
2020-10-15 |
2023-08-23 |
Yeda Research and Development Co. Ltd |
Method of treating myeloid malignancies
|
IL278401A
(en)
|
2020-10-29 |
2022-05-01 |
Yeda Res & Dev |
Polynucleotides for rna editing and methods of using same
|
WO2022097157A2
(en)
|
2020-11-09 |
2022-05-12 |
1E Therapeutics, Ltd. |
Catalytic sequence based methods of treating or preventing bacterial infections
|
CA3200350A1
(en)
|
2020-11-26 |
2022-06-02 |
Yanay OFRAN |
Modified high molecular weight glutenin subunit and uses thereof
|
IL279559A
(en)
|
2020-12-17 |
2022-07-01 |
Yeda Res & Dev |
Controlling ubiquitination of mlkl for treatment of disease
|
EP4267741A2
(en)
|
2020-12-28 |
2023-11-01 |
1E Therapeutics, Ltd. |
P21 mrna target areas for silencing
|
WO2022144883A2
(en)
|
2020-12-28 |
2022-07-07 |
1E Therapeutics, Ltd. |
P21 mrna targeting dnazymes
|
AU2022206415A1
(en)
|
2021-01-10 |
2023-08-17 |
Supermeat The Essence Of Meat Ltd. |
Pluripotent stem cell aggregates and microtissues obtained therefrom for the cultured meat industry
|
US20240083843A1
(en)
|
2021-01-14 |
2024-03-14 |
Yeda Research And Development Co. Ltd. |
Methods of producing vitamin d
|
IL280340B
(en)
|
2021-01-21 |
2022-04-01 |
Yeda Res & Dev |
Antibodies, peptides and combinations of same for the treatment or prevention of coronavirus infection
|
CA3208536A1
(en)
|
2021-02-18 |
2022-08-25 |
Ravid STRAUSSMAN |
Genetically modified bacteria for generating vaccines
|
EP4294428A1
(en)
|
2021-02-18 |
2023-12-27 |
Yeda Research and Development Co. Ltd |
Method of generating vaccines
|
IL281561A
(en)
|
2021-03-16 |
2022-10-01 |
Yeda Res & Dev |
Methods and devices for ex-utero mouse embryonic development
|
WO2022208369A1
(en)
|
2021-03-30 |
2022-10-06 |
Biomx Ltd. |
Pseudomonas bacteriophage and uses thereof
|
IL282188A
(en)
|
2021-04-08 |
2022-11-01 |
Yeda Res & Dev |
A combined use of ketamine and retigabine (ezogabine) for the treatment of psychiatric disorders
|
JP2024520907A
(en)
|
2021-05-12 |
2024-05-27 |
バイオエムエックス・リミテッド |
Staphylococcal bacteriophages and uses thereof
|
IL283563A
(en)
|
2021-05-30 |
2022-12-01 |
Yeda Res & Dev |
Anti-microbial peptide (amp) signatures for diagnostics, stratification, and treatment of microbiome-associated disease
|
CA3219233A1
(en)
|
2021-06-06 |
2022-12-15 |
Ravid STRAUSSMAN |
Combined treatment for cancer
|
IL309333A
(en)
|
2021-06-13 |
2024-02-01 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Method for reprogramming human cells
|
NL2028466B1
(en)
|
2021-06-16 |
2022-12-21 |
Sakata Holland B V |
Methods of sorting matthiola seeds
|
KR20240035997A
(en)
|
2021-06-16 |
2024-03-19 |
시드엑스 테크놀로지스 인코포레이티드 |
Methods for selecting Matiola seeds
|
EP4362662A1
(en)
|
2021-07-02 |
2024-05-08 |
Tropic Biosciences UK Limited |
Delay or prevention of browning in banana fruit
|
AU2022313138A1
(en)
|
2021-07-18 |
2024-02-29 |
Gamida-Cell Ltd. |
Therapeutic nk cell populations
|
WO2023002492A1
(en)
|
2021-07-22 |
2023-01-26 |
Yeda Research And Development Co. Ltd. |
Codon optimization of nucleic acids
|
EP4130028A1
(en)
|
2021-08-03 |
2023-02-08 |
Rhazes Therapeutics Ltd |
Engineered tcr complex and methods of using same
|
WO2023012584A2
(en)
|
2021-08-03 |
2023-02-09 |
Genicity Limited |
Engineered tcr complex and methods of using same
|
IL310716A
(en)
|
2021-08-10 |
2024-04-01 |
Gamida Cell Ltd |
Engineered nk cells, methods of their production and uses thereof
|
GB202112866D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to fusarium wilt in a banana
|
GB202112865D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to black sigatoka disease in banana
|
IL286430A
(en)
|
2021-09-14 |
2023-04-01 |
Yeda Res & Dev |
Multispecific antibodies for use in treating diseases
|
WO2023105526A1
(en)
|
2021-12-08 |
2023-06-15 |
Yeda Research And Development Co. Ltd. |
Multipotent lung progenitor cells for lung regeneration
|
WO2023209708A1
(en)
|
2022-04-25 |
2023-11-02 |
Yeda Research And Development Co. Ltd. |
Compositions for altering cyclic adp-ribose secondary messenger signalling
|